{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:32:15Z","timestamp":1759411935010},"reference-count":291,"publisher":"Bentham Science Publishers Ltd.","issue":"38","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2019,1,3]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Attention deficit hyperactivity (ADHD) disorder is a neurodevelopmental disorder characterized by inattention, hyperactivity, disruptive behaviour, and impulsivity. Despite considered typical of children for a long time, the persistence of ADHD symptoms in adulthood gained increasing interest during the last decades. Indeed, its diagnosis, albeit controversial, is rarely carried out even because ADHD is often comorbid with several other psychiatric diosrders, in particular with bipolar disorders (BDs), a condition that complicates the clinical picture, assessment and treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aims:<\/jats:title><jats:p>The aim of this paper was to systematically review the scientific literature on the neurobiological, clinical features and current pharmacological management of ADHD comorbid with BDs across the entire lifespan, with a major focus on the adulthood.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion:<\/jats:title><jats:p>The pharmacology of ADHD-BD in adults is still empirical and influenced by the individual experience of the clinicians. Stimulants are endowed of a prompt efficacy and safety, whilst non-stimulants are useful when a substance abuse history is detected, although they require some weeks in order to be fully effective. In any case, an in-depth diagnostic and clinical evaluation of the single individual is mandatory.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>The comorbidity of ADHD with BD is still a controversial matter, as it is the notion of adult ADHD as a distinct nosological category. Indeed, some findings highlighted the presence of common neurobiological mechanisms and overlapping clinical features, although disagreement does exist. In any case, while expecting to disentangle this crucial question, a correct management of this comorbidity is essential, which requires the co-administration of mood stabilizers. Further controlled clinical studies in large samples of adult ADHD-BD patients appear extremely urgent in order to better define possible therapeutic guidelines, as well as alternative approaches for this potentially invalidating condition.<\/jats:p><\/jats:sec>","DOI":"10.2174\/0929867326666190805153610","type":"journal-article","created":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T14:45:49Z","timestamp":1565102749000},"page":"6942-6969","update-policy":"http:\/\/dx.doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["ADHD with Comorbid Bipolar Disorders: A Systematic Review of Neurobiological, Clinical and Pharmacological Aspects Across the Lifespan"],"prefix":"10.2174","volume":"26","author":[{"given":"Federico","family":"Mucci","sequence":"first","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Teresa","family":"Avella","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donatella","family":"Marazziti","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","year":"2014","unstructured":"American psychiatric association committee on nomenclature and statistics Diagnostic and Statistical Manual of Mental Disorders 2014","journal-title":"American psychiatric association committee on nomenclature and statistics Diagnostic and Statistical Manual of Mental Disorders"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1093\/jpepsy\/jsm005","volume":"32","author":"Spencer T.J.","year":"2007","unstructured":"Spencer T.J.; Biederman J.; Mick E.; Attention-deficit\/hyperactivity disorder: Diagnosis, lifespan, comorbidities, and neurobiology. J Pediatr Psychol 2007,32(6),631-642","journal-title":"J Pediatr Psychol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s12888-017-1463-3","volume":"17","author":"Katzman M.A.","year":"2017","unstructured":"Katzman M.A.; Bilkey T.S.; Chokka P.R.; Fallu A.; Klassen L.J.; Adult ADHD and comorbid disorders: Clinical implications of a dimensional approach. BMC Psychiatry 2017,17(1),302","journal-title":"BMC Psychiatry"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/j.biopsych.2005.04.001","volume":"57","author":"Kessler R.C.","year":"2005","unstructured":"Kessler R.C.; Adler L.A.; Barkley R.; Biederman J.; Conners C.K.; Faraone S.V.; Greenhill L.L.; Jaeger S.; Secnik K.; Spencer T.; Ust\u00fcn T.B.; Zaslavsky A.M.; Patterns and predictors of attention-deficit\/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication. Biol Psychiatry 2005,57(11),1442-1451","journal-title":"Biol Psychiatry"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1749-6632.2001.tb05770.x","volume":"931","author":"Wender P.H.","year":"2001","unstructured":"Wender P.H.; Wolf L.E.; Wasserstein J.; Adults with ADHD. An overview. Ann N Y Acad Sci 2001,931,1-16","journal-title":"Ann N Y Acad Sci"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1001\/jamapsychiatry.2016.0383","volume":"73","author":"Caye A.","year":"2016","unstructured":"Caye A.; Rocha T.B.; Anselmi L.; Murray J.; Menezes A.M.; Barros F.C.; Gon\u00e7alves H.; Wehrmeister F.; Jensen C.M.; Steinhausen H.C.; Swanson J.M.; Kieling C.; Rohde L.A.; Attention-deficit\/hyperactivity disorder trajectories from childhood to young adulthood: Evidence from a birth cohort supporting a late-onset syndrome. JAMA Psychiatry 2016,73(7),705-712","journal-title":"JAMA Psychiatry"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1001\/jamapsychiatry.2016.0465","volume":"73","author":"Agnew-Blais J.C.","year":"2016","unstructured":"Agnew-Blais J.C.; Polanczyk G.V.; Danese A.; Wertz J.; Moffitt T.E.; Arseneault L.; Evaluation of the persistence, remission, and emergence of attention-deficit\/hyperactivity disorder in young adulthood. JAMA Psychiatry 2016,73(7),713-720","journal-title":"JAMA Psychiatry"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1093\/ije\/dyt261","volume":"43","author":"Polanczyk G.V.","year":"2014","unstructured":"Polanczyk G.V.; Willcutt E.G.; Salum G.A.; Kieling C.; Rohde L.A.; ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis. Int J Epidemiol 2014,43(2),434-442","journal-title":"Int J Epidemiol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1176\/appi.ajp.157.5.816","volume":"157","author":"Biederman J.","year":"2000","unstructured":"Biederman J.; Mick E.; Faraone S.V.; Age-dependent decline of symptoms of attention deficit hyperactivity disorder: Impact of remission definition and symptom type. Am J Psychiatry 2000,157(5),816-818","journal-title":"Am J Psychiatry"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1111\/j.1469-7610.2011.02379.x","volume":"52","author":"Larsson H.","year":"2011","unstructured":"Larsson H.; Dilshad R.; Lichtenstein P.; Barker E.D.; Developmental trajectories of DSM-IV symptoms of attention-deficit\/hyperactivity disorder: genetic effects, family risk and associated psychopathology. J Child Psychol Psychiatry 2011,52(9),954-963","journal-title":"J Child Psychol Psychiatry"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1185\/03007995.2014.915800","volume":"30","author":"Asherson P.","year":"2014","unstructured":"Asherson P.; Young A.H.; Eich-H\u00f6chli D.; Moran P.; Porsdal V.; Deberdt W.; Differential diagnosis, comorbidity, and treatment of attention-deficit\/hyperactivity disorder in relation to bipolar disorder or borderline personality disorder in adults. Curr Med Res Opin 2014,30(8),1657-1672","journal-title":"Curr Med Res Opin"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1017\/S0033291708004236","volume":"39","author":"B\u00e1lint S.","year":"2009","unstructured":"B\u00e1lint S.; Czobor P.; Koml\u00f3si S.; M\u00e9sz\u00e1ros A.; Simon V.; Bitter I.; Attention deficit hyperactivity disorder (ADHD): gender- and age-related differences in neurocognition. Psychol Med 2009,39(8),1337-1345","journal-title":"Psychol Med"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1586\/ern.12.109","volume":"12","author":"Retz W.","year":"2012","unstructured":"Retz W.; Stieglitz R.D.; Corbisiero S.; Retz-Junginger P.; R\u00f6sler M.; Emotional dysregulation in adult ADHD: what is the empirical evidence? Expert Rev Neurother 2012,12(10),1241-1251","journal-title":"Expert Rev Neurother"},{"key":"ref=14","first-page":"23","volume":"24","author":"Bond D.J.","year":"2012","unstructured":"Bond D.J.; Hadjipavlou G.; Lam R.W.; McIntyre R.S.; Beaulieu S.; Schaffer A.; Weiss M.; The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid attention-deficit\/hyperactivity disorder. Ann Clin Psychiatry 2012,24(1),23-37","journal-title":"Ann Clin Psychiatry"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jad.2009.06.036","volume":"124","author":"Klassen L.J.","year":"2010","unstructured":"Klassen L.J.; Katzman M.A.; Chokka P.; Adult ADHD and its comorbidities, with a focus on bipolar disorder. J Affect Disord 2010,124(1-2),1-8","journal-title":"J Affect Disord"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.biopsych.2005.01.036","volume":"57","author":"Nierenberg A.A.","year":"2005","unstructured":"Nierenberg A.A.; Miyahara S.; Spencer T.; Wisniewski S.R.; Otto M.W.; Simon N.; Pollack M.H.; Ostacher M.J.; Yan L.; Siegel R.; Sachs G.S.; Clinical and diagnostic implications of lifetime attention-deficit\/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants. Biol Psychiatry 2005,57(11),1467-1473","journal-title":"Biol Psychiatry"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1037\/pas0000476","volume":"30","author":"Becker S.P.","year":"2018","unstructured":"Becker S.P.; Burns G.L.; Garner A.A.; Jarrett M.A.; Luebbe A.M.; Epstein J.N.; Willcutt E.G.; Sluggish cognitive tempo in adults: Psychometric validation of the adult concentration inventory. Psychol Assess 2018,30(3),296-310","journal-title":"Psychol Assess"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1002\/jclp.22406","volume":"73","author":"Flannery A.J.","year":"2017","unstructured":"Flannery A.J.; Luebbe A.M.; Becker S.P.; Sluggish cognitive tempo is associated with poorer study skills, more executive functioning deficits, and greater impairment in college students. J Clin Psychol 2017,73(9),1091-1113","journal-title":"J Clin Psychol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10802-013-9825-x","volume":"42","author":"Becker S.P.","year":"2014","unstructured":"Becker S.P.; Marshall S.A.; McBurnett K.; Sluggish cognitive tempo in abnormal child psychology: an historical overview and introduction to the special section. J Abnorm Child Psychol 2014,42(1),1-6","journal-title":"J Abnorm Child Psychol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1177\/1087054714527794","volume":"20","author":"Flannery A.J.","year":"2016","unstructured":"Flannery A.J.; Becker S.P.; Luebbe A.M.; Does emotion dysregulation mediate the association between sluggish cognitive tempo and college students\u2019 social impairment? J Atten Disord 2016,20(9),802-812","journal-title":"J Atten Disord"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.2147\/NDT.S111818","volume":"12","author":"Sternat T.","year":"2016","unstructured":"Sternat T.; Katzman M.A.; Neurobiology of hedonic tone: the relationship between treatment-resistant depression, attention-deficit hyperactivity disorder, and substance abuse. Neuropsychiatr Dis Treat 2016,12,2149-2164","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","volume":"68","author":"Merikangas K.R.","year":"2011","unstructured":"Merikangas K.R.; Jin R.; He J.P.; Kessler R.C.; Lee S.; Sampson N.A.; Viana M.C.; Andrade L.H.; Hu C.; Karam E.G.; Ladea M.; Medina-Mora M.E.; Ono Y.; Posada-Villa J.; Sagar R.; Wells J.E.; Zarkov Z.; Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry 2011,68(3),241-251","journal-title":"Arch Gen Psychiatry"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1001\/archpsyc.64.9.1032","volume":"64","author":"Moreno C.","year":"2007","unstructured":"Moreno C.; Laje G.; Blanco C.; Jiang H.; Schmidt A.B.; Olfson M.; National trends in the outpatient diagnosis and treatment of bipolar disorder in youth. Arch Gen Psychiatry 2007,64(9),1032-1039","journal-title":"Arch Gen Psychiatry"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1007\/s11920-015-0604-y","volume":"17","author":"Marangoni C.","year":"2015","unstructured":"Marangoni C.; De Chiara L.; Faedda G.L.; Bipolar disorder and ADHD: comorbidity and diagnostic distinctions. Curr Psychiatry Rep 2015,17(8),604","journal-title":"Curr Psychiatry Rep"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.jpeds.2006.10.070","volume":"150","author":"Leverich G.S.","year":"2007","unstructured":"Leverich G.S.; Post R.M.; Keck P.E.; Altshuler L.L.; Frye M.A.; Kupka R.W.; Nolen W.A.; Suppes T.; McElroy S.L.; Grunze H.; Denicoff K.; Moravec M.K.; Luckenbaugh D.; The poor prognosis of childhood-onset bipolar disorder. J Pediatr 2007,150(5),485-490","journal-title":"J Pediatr"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.4088\/JCP.v68n1118","volume":"68","author":"Wingo A.P.","year":"2007","unstructured":"Wingo A.P.; Ghaemi S.N.; A systematic review of rates and diagnostic validity of comorbid adult attention-deficit\/hyperactivity disorder and bipolar disorder. J Clin Psychiatry 2007,68(11),1776-1784","journal-title":"J Clin Psychiatry"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"PCC.09m00861","DOI":"10.4088\/PCC.09m00861gry","volume":"12","author":"McIntyre R.S.","year":"2010","unstructured":"McIntyre R.S.; Kennedy S.H.; Soczynska J.K.; Nguyen H.T.; Bilkey T.S.; Woldeyohannes H.O.; Nathanson J.A.; Joshi S.; Cheng J.S.; Benson K.M.; Muzina D.J.; Attention deficit\/hyperactivity disorder in adults with bipolar disorder or major depressive disorder: results from the international mood disorders collaborative project. Prim Care Companion J Clin Psychiatry, 2010,12(3),PCC.09m00861","journal-title":"Prim Care Companion J Clin Psychiatry,"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"48","DOI":"10.4088\/JCP.08m04722ora","volume":"71","author":"Halm\u00f8y A.","year":"2010","unstructured":"Halm\u00f8y A.; Halleland H.; Dramsdahl M.; Bergsholm P.; Fasmer O.B.; Haavik J.; Bipolar symptoms in adult attention-deficit\/hyperactivity disorder: a cross-sectional study of 510 clinically diagnosed patients and 417 population-based controls. J Clin Psychiatry 2010,71(1),48-57","journal-title":"J Clin Psychiatry"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1176\/appi.ajp.162.9.1621","volume":"162","author":"McGough J.J.","year":"2005","unstructured":"McGough J.J.; Smalley S.L.; McCracken J.T.; Yang M.; Del\u2019Homme M.; Lynn D.E.; Loo S.; Psychiatric comorbidity in adult attention deficit hyperactivity disorder: findings from multiplex families. Am J Psychiatry 2005,162(9),1621-1627","journal-title":"Am J Psychiatry"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1203\/PDR.0b013e31819e7203","volume":"65","author":"Fombonne E.","year":"2009","unstructured":"Fombonne E.; Epidemiology of pervasive developmental disorders. Pediatr Res 2009,65(6),591-598","journal-title":"Pediatr Res"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.chc.2007.11.006","volume":"17","author":"Polanczyk G.","year":"2008","unstructured":"Polanczyk G.; Jensen P.; Epidemiologic considerations in attention deficit hyperactivity disorder: a review and update. Child Adolesc Psychiatr Clin N Am 2008,17(2),245-260","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/nrn2514","volume":"9","author":"Singh I.","year":"2008","unstructured":"Singh I.; Beyond polemics: science and ethics of ADHD. Nat Rev Neurosci 2008,9(12),957-964","journal-title":"Nat Rev Neurosci"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1097\/01.pra.0000290670.87236.18","volume":"13","author":"Goodman D.W.","year":"2007","unstructured":"Goodman D.W.; The consequences of attention-deficit\/hyperactivity disorder in adults. J Psychiatr Pract 2007,13(5),318-327","journal-title":"J Psychiatr Pract"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.psychres.2010.08.007","volume":"186","author":"Torralva T.","year":"2011","unstructured":"Torralva T.; Gleichgerrcht E.; Torrente F.; Roca M.; Strejilevich S.A.; Cetkovich M.; Lischinsky A.; Manes F.; Neuropsychological functioning in adult bipolar disorder and ADHD patients: a comparative study. Psychiatry Res 2011,186(2-3),261-266","journal-title":"Psychiatry Res"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s11920-007-0054-2","volume":"9","author":"Scheffer R.E.","year":"2007","unstructured":"Scheffer R.E.; Concurrent ADHD and bipolar disorder. Curr Psychiatry Rep 2007,9(5),415-419","journal-title":"Curr Psychiatry Rep"},{"key":"ref=36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000100","volume":"6","author":"Liberati A.","year":"2009","unstructured":"Liberati A.; Altman D.G.; Tetzlaff J.; Mulrow C.; G\u00f8tzsche P.C.; Ioannidis J.P.; Clarke M.; Devereaux P.J.; Kleijnen J.; Moher D.; The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 2009,6(7)","journal-title":"PLoS Med"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S2215-0366(16)00096-1","volume":"3","author":"Gallo E.F.","year":"2016","unstructured":"Gallo E.F.; Posner J.; Moving towards causality in attention-deficit hyperactivity disorder: overview of neural and genetic mechanisms. Lancet Psychiatry 2016,3(6),555-567","journal-title":"Lancet Psychiatry"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1176\/ajp.144.3.330","volume":"144","author":"Biederman J.","year":"1987","unstructured":"Biederman J.; Munir K.; Knee D.; Armentano M.; Autor S.; Waternaux C.; Tsuang M.; High rate of affective disorders in probands with attention deficit disorder and in their relatives: a controlled family study. Am J Psychiatry 1987,144(3),330-333","journal-title":"Am J Psychiatry"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1001\/archpsyc.1991.01810310051009","volume":"48","author":"Biederman J.","year":"1991","unstructured":"Biederman J.; Faraone S.V.; Keenan K.; Tsuang M.T.; Evidence of familial association between attention deficit disorder and major affective disorders. Arch Gen Psychiatry 1991,48(7),633-642","journal-title":"Arch Gen Psychiatry"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.psychres.2005.08.026","volume":"145","author":"Hirshfeld-Becker D.R.","year":"2006","unstructured":"Hirshfeld-Becker D.R.; Biederman J.; Henin A.; Faraone S.V.; Dowd S.T.; De Petrillo L.A.; Markowitz S.M.; Rosenbaum J.F.; Psychopathology in the young offspring of parents with bipolar disorder: a controlled pilot study. Psychiatry Res 2006,145(2-3),155-167","journal-title":"Psychiatry Res"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1177\/1087054708314601","volume":"12","author":"Ghanizadeh A.","year":"2008","unstructured":"Ghanizadeh A.; Mohammadi M.R.; Moini R.; Comorbidity of psychiatric disorders and parental psychiatric disorders in a sample of Iranian children with ADHD. J Atten Disord 2008,12(2),149-155","journal-title":"J Atten Disord"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1176\/appi.ajp.2009.09070977","volume":"167","author":"Birmaher B.","year":"2010","unstructured":"Birmaher B.; Axelson D.; Goldstein B.; Monk K.; Kalas C.; Obreja M.; Hickey M.B.; Iyengar S.; Brent D.; Shamseddeen W.; Diler R.; Kupfer D.; Psychiatric disorders in preschool offspring of parents with bipolar disorder: The Pittsburgh Bipolar Offspring Study (BIOS). Am J Psychiatry 2010,167(3),321-330","journal-title":"Am J Psychiatry"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"599","DOI":"10.4088\/JCP.14m09095","volume":"76","author":"Kim J.W.","year":"2015","unstructured":"Kim J.W.; Yu H.; Ryan N.D.; Axelson D.A.; Goldstein B.I.; Goldstein T.R.; Diler R.S.; Monk K.; Hickey M.B.; Sakolsky D.J.; Merranko J.A.; Birmaher B.; Longitudinal trajectories of ADHD symptomatology in offspring of parents with bipolar disorder and community controls. J Clin Psychiatry 2015,76(5),599-606","journal-title":"J Clin Psychiatry"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1586\/14737175.8.4.611","volume":"8","author":"Krause J.","year":"2008","unstructured":"Krause J.; SPECT and PET of the dopamine transporter in attention-deficit\/hyperactivity disorder. Expert Rev Neurother 2008,8(4),611-625","journal-title":"Expert Rev Neurother"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1523\/JNEUROSCI.4461-11.2012","volume":"32","author":"Volkow N.D.","year":"2012","unstructured":"Volkow N.D.; Wang G.J.; Tomasi D.; Kollins S.H.; Wigal T.L.; Newcorn J.H.; Telang F.W.; Fowler J.S.; Logan J.; Wong C.T.; Swanson J.M.; Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder. J Neurosci 2012,32(3),841-849","journal-title":"J Neurosci"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1600-0447.2007.01058.x","author":"Berk M.","year":"2007","unstructured":"Berk M.; Dodd S.; Kauer-Sant\u2019anna M.; Malhi G.S.; Bourin M.; Kapczinski F.; Norman T.; Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder. Acta Psychiatr Scand Suppl 2007(434),41-49","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1001\/archpsyc.64.3.327","volume":"64","author":"Dunlop B.W.","year":"2007","unstructured":"Dunlop B.W.; Nemeroff C.B.; The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry 2007,64(3),327-337","journal-title":"Arch Gen Psychiatry"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"613","DOI":"10.2165\/00023210-200822070-00006","volume":"22","author":"Dhillon S.","year":"2008","unstructured":"Dhillon S.; Yang L.P.; Curran M.P.; Spotlight on bupropion in major depressive disorder. CNS Drugs 2008,22(7),613-617","journal-title":"CNS Drugs"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2165\/00023210-200418060-00011","volume":"18","author":"Simpson D.","year":"2004","unstructured":"Simpson D.; Plosker G.L.; Spotlight on atomoxetine in adults with attention-deficit hyperactivity disorder. CNS Drugs 2004,18(6),397-401","journal-title":"CNS Drugs"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2165\/11203670-000000000-00000","volume":"24","author":"Garnock-Jones K.P.","year":"2010","unstructured":"Garnock-Jones K.P.; Keating G.M.; Spotlight on atomoxetine in attention-deficit hyperactivity disorder in children and adolescents. CNS Drugs 2010,24(1),85-88","journal-title":"CNS Drugs"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1017\/S0033291707001791","volume":"38","author":"Biederman J.","year":"2008","unstructured":"Biederman J.; Makris N.; Valera E.M.; Monuteaux M.C.; Goldstein J.M.; Buka S.; Boriel D.L.; Bandyopadhyay S.; Kennedy D.N.; Caviness V.S.; Bush G.; Aleardi M.; Hammerness P.; Faraone S.V.; Seidman L.J.; Towards further understanding of the co-morbidity between attention deficit hyperactivity disorder and bipolar disorder: a MRI study of brain volumes. Psychol Med 2008,38(7),1045-1056","journal-title":"Psychol Med"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1744-9081-5-37","volume":"5","author":"Gardner A.","year":"2009","unstructured":"Gardner A.; Salmaso D.; Varrone A.; Sanchez-Crespo A.; Bejerot S.; Jacobsson H.; Larsson S.A.; Pagani M.; Differences at brain SPECT between depressed females with and without adult ADHD and healthy controls: etiological considerations. Behav Brain Funct 2009,5,37","journal-title":"Behav Brain Funct"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1034\/j.1399-5618.2000.020108.x","volume":"2","author":"El-Mallakh R.S.","year":"2000","unstructured":"El-Mallakh R.S.; An open study of methylphenidate in bipolar depression. Bipolar Disord 2000,2(1),56-59","journal-title":"Bipolar Disord"},{"key":"ref=54","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4088\/JCP.v57n1109c","volume":"57","author":"Stoll A.L.","year":"1996","unstructured":"Stoll A.L.; Pillay S.S.; Diamond L.; Workum S.B.; Cole J.O.; Methylphenidate augmentation of serotonin selective reuptake inhibitors: a case series. J Clin Psychiatry 1996,57(2),72-76","journal-title":"J Clin Psychiatry"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11920-017-0758-x","volume":"19","author":"Perugi G.","year":"2017","unstructured":"Perugi G.; Vannucchi G.; Bedani F.; Favaretto E.; Use of stimulants in bipolar disorder. Curr Psychiatry Rep 2017,19(1),7","journal-title":"Curr Psychiatry Rep"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1176\/jnp.14.3.289","volume":"14","author":"Dorrego M.F.","year":"2002","unstructured":"Dorrego M.F.; Canevaro L.; Kuzis G.; Sabe L.; Starkstein S.E.; A randomized, double-blind, crossover study of methylphenidate and lithium in adults with attention-deficit\/hyperactivity disorder: preliminary findings. J Neuropsychiatry Clin Neurosci 2002,14(3),289-295","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1089\/cap.2006.16.665","volume":"16","author":"Barzman D.H.","year":"2006","unstructured":"Barzman D.H.; DelBello M.P.; Adler C.M.; Stanford K.E.; Strakowski S.M.; The efficacy and tolerability of quetiapine versus divalproex for the treatment of impulsivity and reactive aggression in adolescents with co-occurring bipolar disorder and disruptive behavior disorder(s). J Child Adolesc Psychopharmacol 2006,16(6),665-670","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1177\/1087054709332407","volume":"13","author":"Atmaca M.","year":"2009","unstructured":"Atmaca M.; Ozler S.; Topuz M.; Goldstein S.; Attention deficit hyperactivity disorder erroneously diagnosed and treated as bipolar disorder. J Atten Disord 2009,13(2),197-198","journal-title":"J Atten Disord"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1007\/s00702-009-0300-3","volume":"116","author":"Ryd\u00e9n E.","year":"2009","unstructured":"Ryd\u00e9n E.; Johansson C.; Blennow K.; Land\u00e9n M.; Lower C.S.F.; Lower CSF HVA and 5-HIAA in bipolar disorder type 1 with a history of childhood ADHD. J Neural Transm (Vienna) 2009,116(12),1667-1674","journal-title":"J Neural Transm (Vienna)"},{"key":"ref=60","first-page":"109","volume":"9","author":"De Leo D.","year":"1988","unstructured":"De Leo D.; Marazziti D.; Biological prediction of suicide: the role of serotonin. Crisis 1988,9(2),109-118","journal-title":"Crisis"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1007\/s11064-011-0684-y","volume":"37","author":"Marazziti D.","year":"2012","unstructured":"Marazziti D.; Baroni S.; Pirone A.; Giannaccini G.; Betti L.; Schmid L.; Vatteroni E.; Palego L.; Borsini F.; Bordi F.; Piano I.; Gargini C.; Castagna M.; Catena-Dell\u2019osso M.; Lucacchini A.; Distribution of serotonin receptor of type 6 (5-HT) in human brain post-mortem. A pharmacology, autoradiography and immunohistochemistry study. Neurochem Res 2012,37(5),920-927","journal-title":"Neurochem Res"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0165-0327(02)00092-7","volume":"73","author":"Kent L.","year":"2003","unstructured":"Kent L.; Craddock N.; Is there a relationship between attention deficit hyperactivity disorder and bipolar disorder? J Affect Disord 2003,73(3),211-221","journal-title":"J Affect Disord"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"949","DOI":"10.2174\/1381612822666151214104826","volume":"22","author":"Dell\u2019Osso L.","year":"2016","unstructured":"Dell\u2019Osso L.; Carmassi C.; Mucci F.; Marazziti D.; Depression, serotonin and tryptophan. Curr Pharm Des 2016,22(8),949-954","journal-title":"Curr Pharm Des"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"180","DOI":"10.12688\/f1000research.10094.1","volume":"6","author":"Marazziti D.","year":"2017","unstructured":"Marazziti D.; Understanding the role of serotonin in psychiatric diseases. F1000 Res 2017,6,180","journal-title":"F1000 Res"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.biopsych.2006.06.011","volume":"61","author":"Valera E.M.","year":"2007","unstructured":"Valera E.M.; Faraone S.V.; Murray K.E.; Seidman L.J.; Meta-analysis of structural imaging findings in attention-deficit\/hyperactivity disorder. Biol Psychiatry 2007,61(12),1361-1369","journal-title":"Biol Psychiatry"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1017\/S1121189X00005558","volume":"11","author":"Brambilla P.","year":"2002","unstructured":"Brambilla P.; Barale F.; Caverzasi E.; Soares J.C.; Anatomical MRI findings in mood and anxiety disorders. Epidemiol Psichiatr Soc 2002,11(2),88-99","journal-title":"Epidemiol Psichiatr Soc"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0079-6123(00)26027-5","volume":"126","author":"Drevets W.C.","year":"2000","unstructured":"Drevets W.C.; Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression. Prog Brain Res, 2000,126,413-431","journal-title":"Prog Brain Res,"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1600-0447.1997.tb10146.x","volume":"96","author":"Videbech P.","year":"1997","unstructured":"Videbech P.; MRI findings in patients with affective disorder: a meta-analysis. Acta Psychiatr Scand 1997,96(3),157-168","journal-title":"Acta Psychiatr Scand"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1176\/ajp.156.6.891","volume":"156","author":"Rubia K.","year":"1999","unstructured":"Rubia K.; Overmeyer S.; Taylor E.; Brammer M.; Williams S.C.; Simmons A.; Bullmore E.T.; Hypofrontality in attention deficit hyperactivity disorder during higher-order motor control: a study with functional MRI. Am J Psychiatry 1999,156(6),891-896","journal-title":"Am J Psychiatry"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/74737","volume":"6","author":"Teicher M.H.","year":"2000","unstructured":"Teicher M.H.; Anderson C.M.; Polcari A.; Glod C.A.; Maas L.C.; Renshaw P.F.; Functional deficits in basal ganglia of children with attention-deficit\/hyperactivity disorder shown with functional magnetic resonance imaging relaxometry. Nat Med 2000,6(4),470-473","journal-title":"Nat Med"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1080\/15622975.2016.1262060","volume":"19","author":"Bauer J.","year":"2018","unstructured":"Bauer J.; Werner A.; Kohl W.; Kugel H.; Shushakova A.; Pedersen A.; Ohrmann P.; Hyperactivity and impulsivity in adult attention-deficit\/hyperactivity disorder is related to glutamatergic dysfunction in the anterior cingulate cortex. World J Biol Psychiatry 2018,19(7),538-546","journal-title":"World J Biol Psychiatry"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pscychresns.2011.11.003","volume":"202","author":"Makris N.","year":"2012","unstructured":"Makris N.; Seidman L.J.; Brown A.; Valera E.M.; Kaiser J.R.; Petty C.R.; Liang L.; Aleardi M.; Boriel D.; Henderson C.S.; Giddens M.; Faraone S.V.; Spencer T.J.; Biederman J.; Further understanding of the comorbidity between attention-deficit\/hyperactivity disorder and bipolar disorder in adults: an MRI study of cortical thickness. Psychiatry Res 2012,202(1),1-11","journal-title":"Psychiatry Res"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1089\/cap.2008.041","volume":"19","author":"Lopez-Larson M.","year":"2009","unstructured":"Lopez-Larson M.; Michael E.S.; Terry J.E.; Breeze J.L.; Hodge S.M.; Tang L.; Kennedy D.N.; Moore C.M.; Makris N.; Caviness V.S.; Frazier J.A.; Subcortical differences among youths with attention-deficit\/hyperactivity disorder compared to those with bipolar disorder with and without attention-deficit\/hyperactivity disorder. J Child Adolesc Psychopharmacol 2009,19(1),31-39","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1399-5618.2006.00284.x","volume":"8","author":"Lyoo I.K.","year":"2006","unstructured":"Lyoo I.K.; Sung Y.H.; Dager S.R.; Friedman S.D.; Lee J.Y.; Kim S.J.; Kim N.; Dunner D.L.; Renshaw P.F.; Regional cerebral cortical thinning in bipolar disorder. Bipolar Disord 2006,8(1),65-74","journal-title":"Bipolar Disord"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.pscychresns.2007.06.004","volume":"162","author":"Fornito A.","year":"2008","unstructured":"Fornito A.; Malhi G.S.; Lagopoulos J.; Ivanovski B.; Wood S.J.; Saling M.M.; Pantelis C.; Y\u00fccel M.; Anatomical abnormalities of the anterior cingulate and paracingulate cortex in patients with bipolar I disorder. Psychiatry Res 2008,162(2),123-132","journal-title":"Psychiatry Res"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.biopsych.2009.09.032","volume":"67","author":"Rimol L.M.","year":"2010","unstructured":"Rimol L.M.; Panizzon M.S.; Fennema-Notestine C.; Eyler L.T.; Fischl B.; Franz C.E.; Hagler D.J.; Lyons M.J.; Neale M.C.; Pacheco J.; Perry M.E.; Schmitt J.E.; Grant M.D.; Seidman L.J.; Thermenos H.W.; Tsuang M.T.; Eisen S.A.; Kremen W.S.; Dale A.M.; Cortical thickness is influenced by regionally specific genetic factors. Biol Psychiatry 2010,67(5),493-499","journal-title":"Biol Psychiatry"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1016\/S0140-6736(03)14842-8","volume":"362","author":"Sowell E.R.","year":"2003","unstructured":"Sowell E.R.; Thompson P.M.; Welcome S.E.; Henkenius A.L.; Toga A.W.; Peterson B.S.; Cortical abnormalities in children and adolescents with attention-deficit hyperactivity disorder. Lancet 2003,362(9397),1699-1707","journal-title":"Lancet"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1093\/cercor\/bhl047","volume":"17","author":"Makris N.","year":"2007","unstructured":"Makris N.; Biederman J.; Valera E.M.; Bush G.; Kaiser J.; Kennedy D.N.; Caviness V.S.; Faraone S.V.; Seidman L.J.; Cortical thinning of the attention and executive function networks in adults with attention-deficit\/hyperactivity disorder. Cereb Cortex 2007,17(6),1364-1375","journal-title":"Cereb Cortex"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"19649","DOI":"10.1073\/pnas.0707741104","volume":"104","author":"Shaw P.","year":"2007","unstructured":"Shaw P.; Eckstrand K.; Sharp W.; Blumenthal J.; Lerch J.P.; Greenstein D.; Clasen L.; Evans A.; Giedd J.; Rapoport J.L.; Attention-deficit\/hyperactivity disorder is characterized by a delay in cortical maturation. Proc Natl Acad Sci USA 2007,104(49),19649-19654","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/00004583-201003000-00006","volume":"49","author":"Batty M.J.","year":"2010","unstructured":"Batty M.J.; Liddle E.B.; Pitiot A.; Toro R.; Groom M.J.; Scerif G.; Liotti M.; Liddle P.F.; Paus T.; Hollis C.; Cortical gray matter in attention-deficit\/hyperactivity disorder: a structural magnetic resonance imaging study. J Am Acad Child Adolesc Psychiatry 2010,49(3),229-238","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.jpsychires.2010.04.026","volume":"44","author":"Almeida L.G.","year":"2010","unstructured":"Almeida L.G.; Ricardo-Garcell J.; Prado H.; Barajas L.; Fern\u00e1ndez-Bouzas A.; Avila D.; Mart\u00ednez R.B.; Reduced right frontal cortical thickness in children, adolescents and adults with ADHD and its correlation to clinical variables: a cross-sectional study. J Psychiatr Res 2010,44(16),1214-1223","journal-title":"J Psychiatr Res"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1093\/acprof:oso\/9780195134971.003.0024","author":"Mayberg H.","year":"2002","unstructured":"Mayberg H.; Mapping mood: an evolving emphasis on frontal-limbic interactions Principles of frontal lobe function; Stuss, DT 2002,376-391","journal-title":"Mapping mood: an evolving emphasis on frontal-limbic interactions Principles of frontal lobe function; Stuss, DT"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1176\/ajp.151.12.1791","volume":"151","author":"Castellanos F.X.","year":"1994","unstructured":"Castellanos F.X.; Giedd J.N.; Eckburg P.; Marsh W.L.; Vaituzis A.C.; Kaysen D.; Hamburger S.D.; Rapoport J.L.; Quantitative morphology of the caudate nucleus in attention deficit hyperactivity disorder. Am J Psychiatry 1994,151(12),1791-1796","journal-title":"Am J Psychiatry"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1001\/jama.288.14.1740","volume":"288","author":"Castellanos F.X.","year":"2002","unstructured":"Castellanos F.X.; Lee P.P.; Sharp W.; Jeffries N.O.; Greenstein D.K.; Clasen L.S.; Blumenthal J.D.; James R.S.; Ebens C.L.; Walter J.M.; Zijdenbos A.; Evans A.C.; Giedd J.N.; Rapoport J.L.; Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit\/hyperactivity disorder. JAMA 2002,288(14),1740-1748","journal-title":"JAMA"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1046\/j.1399-5618.2003.00087.x","volume":"6","author":"DelBello M.P.","year":"2004","unstructured":"DelBello M.P.; Zimmerman M.E.; Mills N.P.; Getz G.E.; Strakowski S.M.; Magnetic resonance imaging analysis of amygdala and other subcortical brain regions in adolescents with bipolar disorder. Bipolar Disord 2004,6(1),43-52","journal-title":"Bipolar Disord"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1177\/088307389601100210","volume":"11","author":"Aylward E.H.","year":"1996","unstructured":"Aylward E.H.; Reiss A.L.; Reader M.J.; Singer H.S.; Brown J.E.; Denckla M.B.; Basal ganglia volumes in children with attention-deficit hyperactivity disorder. J Child Neurol 1996,11(2),112-115","journal-title":"J Child Neurol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1212\/WNL.48.3.589","volume":"48","author":"Filipek P.A.","year":"1997","unstructured":"Filipek P.A.; Semrud-Clikeman M.; Steingard R.J.; Renshaw P.F.; Kennedy D.N.; Biederman J.; Volumetric MRI analysis comparing subjects having attention-deficit hyperactivity disorder with normal controls. Neurology 1997,48(3),589-601","journal-title":"Neurology"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1017\/S0033291701004706","volume":"31","author":"Overmeyer S.","year":"2001","unstructured":"Overmeyer S.; Bullmore E.T.; Suckling J.; Simmons A.; Williams S.C.; Santosh P.J.; Taylor E.; Distributed grey and white matter deficits in hyperkinetic disorder: MRI evidence for anatomical abnormality in an attentional network. Psychol Med 2001,31(8),1425-1435","journal-title":"Psychol Med"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.pscychresns.2006.09.006","volume":"154","author":"McAlonan G.M.","year":"2007","unstructured":"McAlonan G.M.; Cheung V.; Cheung C.; Chua S.E.; Murphy D.G.; Suckling J.; Tai K.S.; Yip L.K.; Leung P.; Ho T.P.; Mapping brain structure in attention deficit-hyperactivity disorder: a voxel-based MRI study of regional grey and white matter volume. Psychiatry Res 2007,154(2),171-180","journal-title":"Psychiatry Res"},{"key":"ref=90","first-page":"543","volume":"28","author":"Wang J.","year":"2007","unstructured":"Wang J.; Jiang T.; Cao Q.; Wang Y.; Characterizing anatomic differences in boys with attention-deficit\/hyperactivity disorder with the use of deformation-based morphometry. AJNR Am J Neuroradiol 2007,28(3),543-547","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1177\/1087054705284242","volume":"10","author":"Wellington T.M.","year":"2006","unstructured":"Wellington T.M.; Semrud-Clikeman M.; Gregory A.L.; Murphy J.M.; Lancaster J.L.; Magnetic resonance imaging volumetric analysis of the putamen in children with ADHD: combined type versus control. J Atten Disord 2006,10(2),171-180","journal-title":"J Atten Disord"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.pscychresns.2004.01.004","volume":"131","author":"Wilke M.","year":"2004","unstructured":"Wilke M.; Kowatch R.A.; DelBello M.P.; Mills N.P.; Holland S.K.; Voxel-based morphometry in adolescents with bipolar disorder: first results. Psychiatry Res 2004,131(1),57-69","journal-title":"Psychiatry Res"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1196\/annals.1440.011","volume":"1124","author":"Buckner R.L.","year":"2008","unstructured":"Buckner R.L.; Andrews-Hanna J.R.; Schacter D.L.; The brain\u2019s default network: anatomy, function, and relevance to disease. Ann N Y Acad Sci 2008,1124,1-38","journal-title":"Ann N Y Acad Sci"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1073\/pnas.98.2.676","volume":"98","author":"Raichle M.E.","year":"2001","unstructured":"Raichle M.E.; MacLeod A.M.; Snyder A.Z.; Powers W.J.; Gusnard D.A.; Shulman G.L.; A default mode of brain function. Proc Natl Acad Sci USA 2001,98(2),676-682","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1146\/annurev-neuro-071013-014030","volume":"38","author":"Raichle M.E.","year":"2015","unstructured":"Raichle M.E.; The brain\u2019s default mode network. Annu Rev Neurosci 2015,38,433-447","journal-title":"Annu Rev Neurosci"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.neubiorev.2008.09.002","volume":"33","author":"Broyd S.J.","year":"2009","unstructured":"Broyd S.J.; Demanuele C.; Debener S.; Helps S.K.; James C.J.; Sonuga-Barke E.J.; Default-mode brain dysfunction in mental disorders: a systematic review. Neurosci Biobehav Rev 2009,33(3),279-296","journal-title":"Neurosci Biobehav Rev"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.neuroimage.2011.10.035","volume":"62","author":"Buckner R.L.","year":"2012","unstructured":"Buckner R.L.; The serendipitous discovery of the brain\u2019s default network. Neuroimage 2012,62(2),1137-1145","journal-title":"Neuroimage"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.2174\/1871527313666141130205024","volume":"13","author":"Cha D.S.","year":"2014","unstructured":"Cha D.S.; De Michele F.; Soczynska J.K.; Woldeyohannes H.O.; Kaidanovich-Beilin O.; Carvalho A.F.; Malhi G.S.; Patel H.; Sim K.; Brietzke E.; Mansur R.; Dunlop K.A.; Alsuwaidan M.; Baskaran A.; Fagiolini A.; Reznikov R.; Kudlow P.A.; McIntyre R.S.; The putative impact of metabolic health on default mode network activity and functional connectivity in neuropsychiatric disorders. CNS Neurol Disord Drug Targets 2014,13(10),1750-1758","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"663","DOI":"10.3389\/fpsyg.2015.00663","volume":"6","author":"Sala-Llonch R.","year":"2015","unstructured":"Sala-Llonch R.; Bartr\u00e9s-Faz D.; Junqu\u00e9 C.; Reorganization of brain networks in aging: a review of functional connectivity studies. Front Psychol 2015,6,663","journal-title":"Front Psychol"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1503\/jpn.120054","volume":"38","author":"Franzen J.D.","year":"2013","unstructured":"Franzen J.D.; Heinrichs-Graham E.; White M.L.; Wetzel M.W.; Knott N.L.; Wilson T.W.; Atypical coupling between posterior regions of the default mode network in attention-deficit\/hyperactivity disorder: a pharmaco-magnetoencephalography study. J Psychiatry Neurosci 2013,38(5),333-340","journal-title":"J Psychiatry Neurosci"},{"key":"ref=101","doi-asserted-by":"publisher","DOI":"10.3791\/51442","author":"Haneef Z.","year":"2014","unstructured":"Haneef Z.; Lenartowicz A.; Yeh H.J.; Engel J.; Stern J.M.; Network analysis of the default mode network using functional connectivity MRI in temporal lobe epilepsy. J Vis Exp 2014(90)","journal-title":"J Vis Exp"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3389\/fneur.2014.00201","volume":"5","author":"Lopes R.","year":"2014","unstructured":"Lopes R.; Moeller F.; Besson P.; Ogez F.; Szurhaj W.; Leclerc X.; Siniatchkin M.; Chipaux M.; Derambure P.; Tyvaert L.; Study on the relationships between intrinsic functional connectivity of the default mode network and transient epileptic activity. Front Neurol 2014,5,201","journal-title":"Front Neurol"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.3389\/fpsyg.2015.01198","volume":"6","author":"Shi H.","year":"2015","unstructured":"Shi H.; Wang X.; Yi J.; Zhu X.; Zhang X.; Yang J.; Yao S.; Default mode network alterations during implicit emotional faces processing in first-episode, treatment-naive major depression patients. Front Psychol 2015,6,1198","journal-title":"Front Psychol"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11065-014-9249-6","volume":"24","author":"Dennis E.L.","year":"2014","unstructured":"Dennis E.L.; Thompson P.M.; Functional brain connectivity using fMRI in aging and Alzheimer\u2019s disease. Neuropsychol Rev 2014,24(1),49-62","journal-title":"Neuropsychol Rev"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1073\/pnas.0135058100","volume":"100","author":"Greicius M.D.","year":"2003","unstructured":"Greicius M.D.; Krasnow B.; Reiss A.L.; Menon V.; Functional connectivity in the resting brain: a network analysis of the default mode hypothesis. Proc Natl Acad Sci USA 2003,100(1),253-258","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1080\/00207144.2017.1348868","volume":"65","author":"Diolaiuti F.","year":"2017","unstructured":"Diolaiuti F.; Banfi T.; Santarcangelo E.L.; Hypnotizability and the peripersonal space. Int J Clin Exp Hypn 2017,65(4),466-478","journal-title":"Int J Clin Exp Hypn"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.biopsych.2007.06.025","volume":"63","author":"Castellanos F.X.","year":"2008","unstructured":"Castellanos F.X.; Margulies D.S.; Kelly C.; Uddin L.Q.; Ghaffari M.; Kirsch A.; Shaw D.; Shehzad Z.; Di Martino A.; Biswal B.; Sonuga-Barke E.J.; Rotrosen J.; Adler L.A.; Milham M.P.; Cingulate-precuneus interactions: a new locus of dysfunction in adult attention-deficit\/hyperactivity disorder. Biol Psychiatry 2008,63(3),332-337","journal-title":"Biol Psychiatry"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jneumeth.2007.11.031","volume":"169","author":"Uddin L.Q.","year":"2008","unstructured":"Uddin L.Q.; Kelly A.M.; Biswal B.B.; Margulies D.S.; Shehzad Z.; Shaw D.; Ghaffari M.; Rotrosen J.; Adler L.A.; Castellanos F.X.; Milham M.P.; Network homogeneity reveals decreased integrity of default-mode network in ADHD. J Neurosci Methods 2008,169(1),249-254","journal-title":"J Neurosci Methods"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/S0166-2236(98)01374-5","volume":"22","author":"Maddock R.J.","year":"1999","unstructured":"Maddock R.J.; The retrosplenial cortex and emotion: new insights from functional neuroimaging of the human brain. Trends Neurosci 1999,22(7),310-316","journal-title":"Trends Neurosci"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.1073\/pnas.071043098","volume":"98","author":"Gusnard D.A.","year":"2001","unstructured":"Gusnard D.A.; Akbudak E.; Shulman G.L.; Raichle M.E.; Medial prefrontal cortex and self-referential mental activity: relation to a default mode of brain function. Proc Natl Acad Sci USA 2001,98(7),4259-4264","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1073\/pnas.98.2.683","volume":"98","author":"Simpson J.R.","year":"2001","unstructured":"Simpson J.R.; Snyder A.Z.; Gusnard D.A.; Raichle M.E.; Emotion-induced changes in human medial prefrontal cortex: I. During cognitive task performance. Proc Natl Acad Sci USA 2001,98(2),683-687","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11065-014-9251-z","volume":"24","author":"Posner J.","year":"2014","unstructured":"Posner J.; Park C.; Wang Z.; Connecting the dots: a review of resting connectivity MRI studies in attention-deficit\/hyperactivity disorder. Neuropsychol Rev 2014,24(1),3-15","journal-title":"Neuropsychol Rev"},{"key":"ref=113","first-page":"49","volume":"89","author":"Mohan A.","year":"2016","unstructured":"Mohan A.; Roberto A.J.; Mohan A.; Lorenzo A.; Jones K.; Carney M.J.; Liogier-Weyback L.; Hwang S.; Lapidus K.A.; The significance of the Default Mode Network (DMN) in neurological and neuropsychiatric disorders: a review. Yale J Biol Med 2016,89(1),49-57","journal-title":"Yale J Biol Med"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.nicl.2015.01.004","volume":"7","author":"van Rooij D.","year":"2015","unstructured":"van Rooij D.; Hartman C.A.; Mennes M.; Oosterlaan J.; Franke B.; Rommelse N.; Heslenfeld D.; Faraone S.V.; Buitelaar J.K.; Hoekstra P.J.; Altered neural connectivity during response inhibition in adolescents with attention-deficit\/hyperactivity disorder and their unaffected siblings. Neuroimage Clin 2015,7,325-335","journal-title":"Neuroimage Clin"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1111\/j.1469-7610.2010.02333.x","volume":"52","author":"Liddle E.B.","year":"2011","unstructured":"Liddle E.B.; Hollis C.; Batty M.J.; Groom M.J.; Totman J.J.; Liotti M.; Scerif G.; Liddle P.F.; Task-related default mode network modulation and inhibitory control in ADHD: effects of motivation and methylphenidate. J Child Psychol Psychiatry 2011,52(7),761-771","journal-title":"J Child Psychol Psychiatry"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.neuroimage.2007.03.071","volume":"37","author":"Cole M.W.","year":"2007","unstructured":"Cole M.W.; Schneider W.; The cognitive control network: Integrated cortical regions with dissociable functions. Neuroimage 2007,37(1),343-360","journal-title":"Neuroimage"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.pscychresns.2011.07.001","volume":"201","author":"Sun L.","year":"2012","unstructured":"Sun L.; Cao Q.; Long X.; Sui M.; Cao X.; Zhu C.; Zuo X.; An L.; Song Y.; Zang Y.; Wang Y.; Abnormal functional connectivity between the anterior cingulate and the default mode network in drug-na\u00efve boys with attention deficit hyperactivity disorder. Psychiatry Res 2012,201(2),120-127","journal-title":"Psychiatry Res"},{"key":"ref=118","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045671","volume":"7","author":"Sato J.R.","year":"2012","unstructured":"Sato J.R.; Hoexter M.Q.; Castellanos X.F.; Rohde L.A.; Abnormal brain connectivity patterns in adults with ADHD: a coherence study. PLoS One 2012,7(9)","journal-title":"PLoS One"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1002\/hbm.22250","volume":"35","author":"Hoekzema E.","year":"2014","unstructured":"Hoekzema E.; Carmona S.; Ramos-Quiroga J.A.; Richarte Fern\u00e1ndez V.; Bosch R.; Soliva J.C.; Rovira M.; Bulbena A.; Tobe\u00f1a A.; Casas M.; Vilarroya O.; An independent components and functional connectivity analysis of resting state fMRI data points to neural network dysregulation in adult ADHD. Hum Brain Mapp 2014,35(4),1261-1272","journal-title":"Hum Brain Mapp"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.biopsych.2011.10.035","volume":"71","author":"Zhu X.","year":"2012","unstructured":"Zhu X.; Wang X.; Xiao J.; Liao J.; Zhong M.; Wang W.; Yao S.; Evidence of a dissociation pattern in resting-state default mode network connectivity in first-episode, treatment-naive major depression patients. Biol Psychiatry 2012,71(7),611-617","journal-title":"Biol Psychiatry"},{"key":"ref=121","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0071368","volume":"8","author":"Guo W.","year":"2013","unstructured":"Guo W.; Liu F.; Xue Z.; Gao K.; Liu Z.; Xiao C.; Chen H.; Zhao J.; Decreased interhemispheric coordination in treatment-resistant depression: a resting-state fMRI study. PLoS One 2013,8(8)","journal-title":"PLoS One"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1097\/WNR.0000000000000407","volume":"26","author":"Qin J.","year":"2015","unstructured":"Qin J.; Shen H.; Zeng L.L.; Jiang W.; Liu L.; Hu D.; Predicting clinical responses in major depression using intrinsic functional connectivity. Neuroreport 2015,26(12),675-680","journal-title":"Neuroreport"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jad.2013.05.083","volume":"150","author":"Vargas C.","year":"2013","unstructured":"Vargas C.; L\u00f3pez-Jaramillo C.; Vieta E.; A systematic literature review of resting state network--functional MRI in bipolar disorder. J Affect Disord 2013,150(3),727-735","journal-title":"J Affect Disord"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/s11920-014-0524-2","volume":"16","author":"Dell\u2019Osso B.","year":"2014","unstructured":"Dell\u2019Osso B.; Dobrea C.; Cremaschi L.; Arici C.; Altamura A.C.; Wake-promoting pharmacotherapy for psychiatric disorders. Curr Psychiatry Rep 2014,16(12),524","journal-title":"Curr Psychiatry Rep"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1592\/phco.23.12.1281.32697","volume":"23","author":"Markowitz J.S.","year":"2003","unstructured":"Markowitz J.S.; Straughn A.B.; Patrick K.S.; Advances in the pharmacotherapy of attention-deficit-hyperactivity disorder: focus on methylphenidate formulations. Pharmacotherapy 2003,23(10),1281-1299","journal-title":"Pharmacotherapy"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1002\/hlca.194402701222","volume":"27","author":"Panizzon L.","year":"1944","unstructured":"Panizzon L.; The preparation of pyridyl- and piperidyl-arylacetonitriles and some transformation products (Part Ia). Helv Chim Acta 1944,27(1),1748-1756","journal-title":"Helv Chim Acta"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/j.biopsych.2004.08.019","volume":"57","author":"Arnsten A.F.","year":"2005","unstructured":"Arnsten A.F.; Li B.M.; Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions. Biol Psychiatry 2005,57(11),1377-1384","journal-title":"Biol Psychiatry"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1097\/JCP.0b013e3181733560","volume":"28","author":"Markowitz J.S.","year":"2008","unstructured":"Markowitz J.S.; Patrick K.S.; Differential pharmacokinetics and pharmacodynamics of methylphenidate enantiomers: does chirality matter? J Clin Psychopharmacol 2008,28(3)(Suppl. 2),S54-S61","journal-title":"J Clin Psychopharmacol"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/FBP.0b013e3280143226","volume":"18","author":"Williard R.L.","year":"2007","unstructured":"Williard R.L.; Middaugh L.D.; Zhu H.J.; Patrick K.S.; Methylphenidate and its ethanol transesterification metabolite ethylphenidate: brain disposition, monoamine transporters and motor activity. Behav Pharmacol 2007,18(1),39-51","journal-title":"Behav Pharmacol"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1089\/cap.2006.16.687","volume":"16","author":"Markowitz J.S.","year":"2006","unstructured":"Markowitz J.S.; DeVane C.L.; Pestreich L.K.; Patrick K.S.; Muniz R.; A comprehensive in vitro screening of d-, l-, and dl-threo-methylphenidate: an exploratory study. J Child Adolesc Psychopharmacol 2006,16(6),687-698","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"ref=131","unstructured":"Canadian Attention Deficit Hyperactivity Resource Alliance Assessment and treatment of ADHD uncomplicated- adults. Available at: [Accessed: December 8th, 2017]."},{"key":"ref=132","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1542\/peds.72.1.56","volume":"72","author":"Chan Y.P.","year":"1983","unstructured":"Chan Y.P.; Swanson J.M.; Soldin S.S.; Thiessen J.J.; Macleod S.M.; Logan W.; Methylphenidate hydrochloride given with or before breakfast: II. Effects on plasma concentration of methylphenidate and ritalinic acid. Pediatrics 1983,72(1),56-59","journal-title":"Pediatrics"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/jcph.642","volume":"56","author":"Lehmann D.F.","year":"2016","unstructured":"Lehmann D.F.; Wojnowicz S.; The evergreening of biopharmaceuticals: Time to defoliate. J Clin Pharmacol 2016,56(4),383-389","journal-title":"J Clin Pharmacol"},{"key":"ref=134","first-page":"123","volume":"64","author":"Markowitz J.S.","year":"2009","unstructured":"Markowitz J.S.; DeVane C.L.; Ramamoorthy S.; Zhu H.J.; The psychostimulant d-threo-(R,R)-methylphenidate binds as an agonist to the 5HT(1A) receptor. Pharmazie 2009,64(2),123-125","journal-title":"Pharmazie"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"713","DOI":"10.2165\/00023210-200620090-00002","volume":"20","author":"Heal D.J.","year":"2006","unstructured":"Heal D.J.; Pierce D.M.; Methylphenidate and its isomers: their role in the treatment of attention-deficit hyperactivity disorder using a transdermal delivery system. CNS Drugs 2006,20(9),713-738","journal-title":"CNS Drugs"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"S82","DOI":"10.1038\/sj.bjp.0706428","volume":"147","author":"Iversen L.","year":"2006","unstructured":"Iversen L.; Neurotransmitter transporters and their impact on the development of psychopharmacology. Br J Pharmacol 2006,147(Suppl. 1),S82-S88","journal-title":"Br J Pharmacol"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1177\/070674370200601S05","volume":"6","author":"Volkow N.D.","year":"2002","unstructured":"Volkow N.D.; Fowler J.S.; Wang G.; Ding Y.; Gatley S.J.; Mechanism of action of methylphenidate: insights from PET imaging studies. J Atten Disord 2002,6(Suppl. 1),S31-S43","journal-title":"J Atten Disord"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00787-012-0286-5","volume":"21","author":"Hodgkins P.","year":"2012","unstructured":"Hodgkins P.; Shaw M.; Coghill D.; Hechtman L.; Amfetamine and methylphenidate medications for attention-deficit\/hyperactivity disorder: complementary treatment options. Eur Child Adolesc Psychiatry 2012,21(9),477-492","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.biopsych.2006.04.022","volume":"60","author":"Berridge C.W.","year":"2006","unstructured":"Berridge C.W.; Devilbiss D.M.; Andrzejewski M.E.; Arnsten A.F.; Kelley A.E.; Schmeichel B.; Hamilton C.; Spencer R.C.; Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol Psychiatry 2006,60(10),1111-1120","journal-title":"Biol Psychiatry"},{"key":"ref=140","author":"Stahl S.M.","year":"2017","unstructured":"Stahl S.M.; Stahl\u2019s essential psychopharmacology: prescriber\u2019s guide 2017","journal-title":"Stahl\u2019s essential psychopharmacology: prescriber\u2019s guide"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00213-007-0996-4","volume":"197","author":"Peterson K.","year":"2008","unstructured":"Peterson K.; McDonagh M.S.; Fu R.; Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis. Psychopharmacology (Berl) 2008,197(1),1-11","journal-title":"Psychopharmacology (Berl)"},{"key":"ref=142","unstructured":"National Institute for Health and Care Excellence (NICE). Attention deficit hyperactivity disorder: diagnosis and management. Available at: [Accessed: December 8th, 2017]."},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1097\/chi.0b013e31814b8d3b","volume":"46","author":"Findling R.L.","year":"2007","unstructured":"Findling R.L.; Short E.J.; McNamara N.K.; Demeter C.A.; Stansbrey R.J.; Gracious B.L.; Whipkey R.; Manos M.J.; Calabrese J.R.; Methylphenidate in the treatment of children and adolescents with bipolar disorder and attention-deficit\/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2007,46(11),1445-1453","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1089\/cap.2009.0037","volume":"19","author":"Zeni C.P.","year":"2009","unstructured":"Zeni C.P.; Tramontina S.; Ketzer C.R.; Pheula G.F.; Rohde L.A.; Methylphenidate combined with aripiprazole in children and adolescents with bipolar disorder and attention-deficit\/hyperactivity disorder: a randomized crossover trial. J Child Adolesc Psychopharmacol 2009,19(5),553-561","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1176\/ajp.2006.163.7.1149","volume":"163","author":"Ross R.G.","year":"2006","unstructured":"Ross R.G.; Psychotic and manic-like symptoms during stimulant treatment of attention deficit hyperactivity disorder. Am J Psychiatry 2006,163(7),1149-1152","journal-title":"Am J Psychiatry"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1097\/WNF.0b013e3181e29174","volume":"33","author":"Kraemer M.","year":"2010","unstructured":"Kraemer M.; Uekermann J.; Wiltfang J.; Kis B.; Methylphenidate-induced psychosis in adult attention-deficit\/hyperactivity disorder: report of 3 new cases and review of the literature. Clin Neuropharmacol 2010,33(4),204-206","journal-title":"Clin Neuropharmacol"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1097\/WNF.0b013e3182206dc1","volume":"34","author":"Manor I.","year":"2011","unstructured":"Manor I.; Rozen S.; Zemishlani Z.; Weizman A.; Zalsman G.; When does it end? Attention-deficit\/hyperactivity disorder in the middle aged and older populations. Clin Neuropharmacol 2011,34(4),148-154","journal-title":"Clin Neuropharmacol"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2147\/NDT.S59271","volume":"12","author":"Torgersen T.","year":"2016","unstructured":"Torgersen T.; Gjervan B.; Lensing M.B.; Rasmussen K.; Optimal management of ADHD in older adults. Neuropsychiatr Dis Treat 2016,12,79-87","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.amjopharm.2009.02.006","volume":"7","author":"Hardy S.E.","year":"2009","unstructured":"Hardy S.E.; Methylphenidate for the treatment of depressive symptoms, including fatigue and apathy, in medically ill older adults and terminally ill adults. Am J Geriatr Pharmacother 2009,7(1),34-59","journal-title":"Am J Geriatr Pharmacother"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s12325-013-0085-5","volume":"31","author":"Huss M.","year":"2014","unstructured":"Huss M.; Ginsberg Y.; Tvedten T.; Arngrim T.; Philipsen A.; Carter K.; Chen C.W.; Kumar V.; Methylphenidate hydrochloride modified-release in adults with attention deficit hyperactivity disorder: a randomized double-blind placebo-controlled trial. Adv Ther 2014,31(1),44-65","journal-title":"Adv Ther"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s11910-003-0004-2","volume":"3","author":"Kurlan R.","year":"2003","unstructured":"Kurlan R.; Tourette\u2019s syndrome: are stimulants safe? Curr Neurol Neurosci Rep 2003,3(4),285-288","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/WNF.0000000000000075","volume":"38","author":"T\u00fcrko\u011flu S.","year":"2015","unstructured":"T\u00fcrko\u011flu S.; Serotonin syndrome with sertraline and methylphenidate in an adolescent. Clin Neuropharmacol 2015,38(2),65-66","journal-title":"Clin Neuropharmacol"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/j.1440-1819.2008.01767.x","volume":"62","author":"Ishii M.","year":"2008","unstructured":"Ishii M.; Tatsuzawa Y.; Yoshino A.; Nomura S.; Serotonin syndrome induced by augmentation of SSRI with methylphenidate. Psychiatry Clin Neurosci 2008,62(2),246","journal-title":"Psychiatry Clin Neurosci"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1212\/WNL.45.2.219","volume":"45","author":"Bodner R.A.","year":"1995","unstructured":"Bodner R.A.; Lynch T.; Lewis L.; Kahn D.; Serotonin syndrome. Neurology 1995,45(2),219-223","journal-title":"Neurology"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3109\/03602539709037587","volume":"29","author":"Roberts S.M.","year":"1997","unstructured":"Roberts S.M.; DeMott R.P.; James R.C.; Adrenergic modulation of hepatotoxicity. Drug Metab Rev 1997,29(1-2),329-353","journal-title":"Drug Metab Rev"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1002\/pds.3600","volume":"23","author":"Haervig K.B.","year":"2014","unstructured":"Haervig K.B.; Mortensen L.H.; Hansen A.V.; Strandberg-Larsen K.; Use of ADHD medication during pregnancy from 1999 to 2010: A Danish register-based study. Pharmacoepidemiol Drug Saf 2014,23(5),526-533","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1177\/0269881113482532","volume":"27","author":"Heal D.J.","year":"2013","unstructured":"Heal D.J.; Smith S.L.; Gosden J.; Nutt D.J.; Amphetamine, past and present--a pharmacological and clinical perspective. J Psychopharmacol (Oxford) 2013,27(6),479-496","journal-title":"J Psychopharmacol (Oxford)"},{"key":"ref=158","author":"Goodman L.S.","year":"2011","unstructured":"Goodman L.S.; Gilman A.G.; Brunton L.L.; Chabner B.A.; Knollmann Bj\u00f6rn C.; Goodman 2011","journal-title":"Goodman"},{"key":"ref=159","author":"Foye W.O.","year":"1996","unstructured":"Foye W.O.; Lemke T.L.; Williams D.A.; Principles of medicinal chemistry 1996","journal-title":"Principles of medicinal chemistry"},{"key":"ref=160","author":"Adderal X.R.","unstructured":"Adderal X.R.; Prescribing information Available at:[Accessed: December 8th, 2017]","journal-title":"Prescribing information"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1471-4159.2010.07109.x","volume":"116","author":"Miller G.M.","year":"2011","unstructured":"Miller G.M.; The emerging role of trace amine-associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activity. J Neurochem 2011,116(2),164-176","journal-title":"J Neurochem"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.pbb.2011.05.002","volume":"99","author":"Bidwell L.C.","year":"2011","unstructured":"Bidwell L.C.; McClernon F.J.; Kollins S.H.; Cognitive enhancers for the treatment of ADHD. Pharmacol Biochem Behav 2011,99(2),262-274","journal-title":"Pharmacol Biochem Behav"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.pharmthera.2009.11.005","volume":"125","author":"Broadley K.J.","year":"2010","unstructured":"Broadley K.J.; The vascular effects of trace amines and amphetamines. Pharmacol Ther 2010,125(3),363-375","journal-title":"Pharmacol Ther"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.neuron.2014.05.043","volume":"83","author":"Underhill S.M.","year":"2014","unstructured":"Underhill S.M.; Wheeler D.S.; Li M.; Watts S.D.; Ingram S.L.; Amara S.G.; Amphetamine modulates excitatory neurotransmission through endocytosis of the glutamate transporter EAAT3 in dopamine neurons. Neuron 2014,83(2),404-416","journal-title":"Neuron"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.biopsych.2014.09.013","volume":"77","author":"Spencer R.C.","year":"2015","unstructured":"Spencer R.C.; Devilbiss D.M.; Berridge C.W.; The cognition-enhancing effects of psychostimulants involve direct action in the prefrontal cortex. Biol Psychiatry 2015,77(11),940-950","journal-title":"Biol Psychiatry"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1162\/jocn_a_00776","volume":"27","author":"Ilieva I.P.","year":"2015","unstructured":"Ilieva I.P.; Hook C.J.; Farah M.J.; Prescription stimulants\u2019 effects on healthy inhibitory control, working memory, and episodic memory: A meta-analysis. J Cogn Neurosci 2015,27(6),1069-1089","journal-title":"J Cogn Neurosci"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/add.12460","volume":"109","author":"Bagot K.S.","year":"2014","unstructured":"Bagot K.S.; Kaminer Y.; Efficacy of stimulants for cognitive enhancement in non-attention deficit hyperactivity disorder youth: a systematic review. Addiction 2014,109(4),547-557","journal-title":"Addiction"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1124\/pr.112.007054","volume":"66","author":"Wood S.","year":"2013","unstructured":"Wood S.; Sage J.R.; Shuman T.; Anagnostaras S.G.; Psychostimulants and cognition: a continuum of behavioral and cognitive activation. Pharmacol Rev 2013,66(1),193-221","journal-title":"Pharmacol Rev"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1016\/j.peptides.2005.11.028","volume":"27","author":"Philpot K.","year":"2006","unstructured":"Philpot K.; Smith Y.; CART peptide and the mesolimbic dopamine system. Peptides 2006,27(8),1987-1992","journal-title":"Peptides"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1001\/jamapsychiatry.2017.0135","volume":"74","author":"Ashok A.H.","year":"2017","unstructured":"Ashok A.H.; Mizuno Y.; Volkow N.D.; Howes O.D.; Association of stimulant use with dopaminergic alterations in users of cocaine, amphetamine, or methamphetamine: a systematic review and meta-analysis. JAMA Psychiatry 2017,74(5),511-519","journal-title":"JAMA Psychiatry"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1176\/appi.ajp.162.1.58","volume":"162","author":"Scheffer R.E.","year":"2005","unstructured":"Scheffer R.E.; Kowatch R.A.; Carmody T.; Rush A.J.; Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium. Am J Psychiatry 2005,162(1),58-64","journal-title":"Am J Psychiatry"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/j.1600-0447.2009.01434.x","volume":"121","author":"Parker G.","year":"2010","unstructured":"Parker G.; Brotchie H.; Do the old psychostimulant drugs have a role in managing treatment-resistant depression? Acta Psychiatr Scand 2010,121(4),308-314","journal-title":"Acta Psychiatr Scand"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/j.1399-5618.2004.00132.x","volume":"6","author":"Carlson P.J.","year":"2004","unstructured":"Carlson P.J.; Merlock M.C.; Suppes T.; Adjunctive stimulant use in patients with bipolar disorder: treatment of residual depression and sedation. Bipolar Disord 2004,6(5),416-420","journal-title":"Bipolar Disord"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1001\/jamapsychiatry.2013.277","volume":"70","author":"Hart H.","year":"2013","unstructured":"Hart H.; Radua J.; Nakao T.; Mataix-Cols D.; Rubia K.; Meta-analysis of functional magnetic resonance imaging studies of inhibition and attention in attention-deficit\/hyperactivity disorder: exploring task-specific, stimulant medication, and age effects. JAMA Psychiatry 2013,70(2),185-198","journal-title":"JAMA Psychiatry"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"902","DOI":"10.4088\/JCP.12r08287","volume":"74","author":"Spencer T.J.","year":"2013","unstructured":"Spencer T.J.; Brown A.; Seidman L.J.; Valera E.M.; Makris N.; Lomedico A.; Faraone S.V.; Biederman J.; Effect of psychostimulants on brain structure and function in ADHD: a qualitative literature review of magnetic resonance imaging-based neuroimaging studies. J Clin Psychiatry 2013,74(9),902-917","journal-title":"J Clin Psychiatry"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/j.1600-0447.2011.01786.x","volume":"125","author":"Frodl T.","year":"2012","unstructured":"Frodl T.; Skokauskas N.; Meta-analysis of structural MRI studies in children and adults with attention deficit hyperactivity disorder indicates treatment effects. Acta Psychiatr Scand 2012,125(2),114-126","journal-title":"Acta Psychiatr Scand"},{"key":"ref=177","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116407","volume":"10","author":"Arnold L.E.","year":"2015","unstructured":"Arnold L.E.; Hodgkins P.; Caci H.; Kahle J.; Young S.; Effect of treatment modality on long-term outcomes in attention-deficit\/hyperactivity disorder: a systematic review. PLoS One 2015,10(2)","journal-title":"PLoS One"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/00007611-199601000-00005","volume":"89","author":"Kessler S.","year":"1996","unstructured":"Kessler S.; Drug therapy in attention-deficit hyperactivity disorder. South Med J 1996,89(1),33-38","journal-title":"South Med J"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1471-2261-12-41","volume":"12","author":"Westover A.N.","year":"2012","unstructured":"Westover A.N.; Halm E.A.; Do prescription stimulants increase the risk of adverse cardiovascular events?: A systematic review. BMC Cardiovasc Disord 2012,12,41","journal-title":"BMC Cardiovasc Disord"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/phar.1576","volume":"35","author":"Thomas S.J.","year":"2015","unstructured":"Thomas S.J.; Shin M.; McInnis M.G.; Bostwick J.R.; Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression. Pharmacotherapy 2015,35(4),433-449","journal-title":"Pharmacotherapy"},{"key":"ref=181","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.15br01836","volume":"17","author":"Israel J.A.","year":"2015","unstructured":"Israel J.A.; Combining stimulants and monoamine oxidase inhibitors: A reexamination of the literature and a report of a new treatment combination. Prim Care Companion CNS Disord 2015,17(6)","journal-title":"Prim Care Companion CNS Disord"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.4088\/JCP.v65n1113","volume":"65","author":"Feinberg S.S.","year":"2004","unstructured":"Feinberg S.S.; Combining stimulants with monoamine oxidase inhibitors: a review of uses and one possible additional indication. J Clin Psychiatry 2004,65(11),1520-1524","journal-title":"J Clin Psychiatry"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"18f12108.","DOI":"10.4088\/JCP.18f12108","volume":"79","author":"Andrade C.","year":"2018","unstructured":"Andrade C.; Risk of major congenital malformations associated with the use of methylphenidate or amphetamines in pregnancy. J Clin Psychiatry 2018,79(1),18f12108.","journal-title":"J Clin Psychiatry"},{"key":"ref=184","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1365-2125.2009.03366.x","volume":"67","author":"Bartu A.","year":"2009","unstructured":"Bartu A.; Dusci L.J.; Ilett K.F.; Transfer of methylamphetamine and amphetamine into breast milk following recreational use of methylamphetamine. Br J Clin Pharmacol 2009,67(4),455-459","journal-title":"Br J Clin Pharmacol"},{"key":"ref=185","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1136\/eb-2014-101805","volume":"17","author":"Ghuman J.K.","year":"2014","unstructured":"Ghuman J.K.; Hutchison S.L.; Atomoxetine is a second-line medication treatment option for ADHD. Evid Based Ment Health 2014,17(4),108","journal-title":"Evid Based Ment Health"},{"key":"ref=186","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.drugalcdep.2008.01.008","volume":"95","author":"Jasinski D.R.","year":"2008","unstructured":"Jasinski D.R.; Faries D.E.; Moore R.J.; Schuh L.M.; Allen A.J.; Abuse liability assessment of atomoxetine in a drug-abusing population. Drug Alcohol Depend 2008,95(1-2),140-146","journal-title":"Drug Alcohol Depend"},{"key":"ref=187","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S0006-3223(02)01671-2","volume":"53","author":"Michelson D.","year":"2003","unstructured":"Michelson D.; Adler L.; Spencer T.; Reimherr F.W.; West S.A.; Allen A.J.; Kelsey D.; Wernicke J.; Dietrich A.; Milton D.; Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biol Psychiatry 2003,53(2),112-120","journal-title":"Biol Psychiatry"},{"key":"ref=188","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.drugalcdep.2008.02.009","volume":"96","author":"Wilens T.E.","year":"2008","unstructured":"Wilens T.E.; Adler L.A.; Weiss M.D.; Michelson D.; Ramsey J.L.; Moore R.J.; Renard D.; Brady K.T.; Trzepacz P.T.; Schuh L.M.; Ahrbecker L.M.; Levine L.R.; Atomoxetine A.S.U.D.S.G.; Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders. Drug Alcohol Depend 2008,96(1-2),145-154","journal-title":"Drug Alcohol Depend"},{"key":"ref=189","author":"Taylor D.","year":"2012","unstructured":"Taylor D.; Kapur S.; Paton C.; Maudsley H.; The Maudsley prescribing guidelines in psychiatry 2012","journal-title":"The Maudsley prescribing guidelines in psychiatry"},{"key":"ref=190","doi-asserted-by":"publisher","first-page":"571","DOI":"10.2165\/00003088-200544060-00002","volume":"44","author":"Sauer J.M.","year":"2005","unstructured":"Sauer J.M.; Ring B.J.; Witcher J.W.; Clinical pharmacokinetics of atomoxetine. Clin Pharmacokinet 2005,44(6),571-590","journal-title":"Clin Pharmacokinet"},{"key":"ref=191","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.2217\/PGS.15.93","volume":"16","author":"Brown J.T.","year":"2015","unstructured":"Brown J.T.; Bishop J.R.; Atomoxetine pharmacogenetics: associations with pharmacokinetics, treatment response and tolerability. Pharmacogenomics 2015,16(13),1513-1520","journal-title":"Pharmacogenomics"},{"key":"ref=192","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1471-4159.2010.06750.x","volume":"114","author":"Koda K.","year":"2010","unstructured":"Koda K.; Ago Y.; Cong Y.; Kita Y.; Takuma K.; Matsuda T.; Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice. J Neurochem 2010,114(1),259-270","journal-title":"J Neurochem"},{"key":"ref=193","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1089\/cap.2009.0030","volume":"19","author":"Chang K.","year":"2009","unstructured":"Chang K.; Nayar D.; Howe M.; Rana M.; Atomoxetine as an adjunct therapy in the treatment of co-morbid attention-deficit\/hyperactivity disorder in children and adolescents with bipolar I or II disorder. J Child Adolesc Psychopharmacol 2009,19(5),547-551","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"ref=194","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.genhosppsych.2008.08.006","volume":"30","author":"Castaneda R.","year":"2008","unstructured":"Castaneda R.; Levy R.; Hazzi C.; Ross S.; Roman W.; Hamid H.; Treating adult attention deficit hyperactivity disorder in hospitalized psychiatric patients. Gen Hosp Psychiatry 2008,30(6),572-577","journal-title":"Gen Hosp Psychiatry"},{"key":"ref=195","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1176\/ajp.142.12.1517","volume":"142","author":"Steinberg S.","year":"1985","unstructured":"Steinberg S.; Chouinard G.; A case of mania associated with tomoxetine. Am J Psychiatry 1985,142(12),1517-1518","journal-title":"Am J Psychiatry"},{"key":"ref=196","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4103\/0253-7176.198954","volume":"39","author":"Kumar V.","year":"2017","unstructured":"Kumar V.; Varambally S.; Atomoxetine induced hypomania in a patient with bipolar disorder and adult attention deficit hyperactivity disorder. Indian J Psychol Med 2017,39(1),89-91","journal-title":"Indian J Psychol Med"},{"key":"ref=197","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1542\/peds.2004-1140","volume":"114","author":"Henderson T.A.","year":"2004","unstructured":"Henderson T.A.; Hartman K.; Aggression, mania, and hypomania induction associated with atomoxetine. Pediatrics 2004,114(3),895-896","journal-title":"Pediatrics"},{"key":"ref=198","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.neubiorev.2017.08.010","volume":"84","author":"Lenzi F.","year":"2018","unstructured":"Lenzi F.; Cortese S.; Harris J.; Masi G.; Pharmacotherapy of emotional dysregulation in adults with ADHD: a systematic review and meta-analysis. Neurosci Biobehav Rev 2018,84,359-367","journal-title":"Neurosci Biobehav Rev"},{"key":"ref=199","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1185\/03007995.2011.628648","volume":"27","author":"Wilens T.E.","year":"2011","unstructured":"Wilens T.E.; Adler L.A.; Tanaka Y.; Xiao F.; D\u2019Souza D.N.; Gutkin S.W.; Upadhyaya H.P.; Correlates of alcohol use in adults with ADHD and comorbid alcohol use disorders: exploratory analysis of a placebo-controlled trial of atomoxetine. Curr Med Res Opin 2011,27(12),2309-2320","journal-title":"Curr Med Res Opin"},{"key":"ref=200","doi-asserted-by":"publisher","first-page":"198","DOI":"10.18433\/J3H03R","volume":"19","author":"Todor I.","year":"2016","unstructured":"Todor I.; Popa A.; Neag M.; Muntean D.; Bocsan C.; Buzoianu A.; Vlase L.; Gheldiu A.M.; Briciu C.; Evaluation of a potential metabolism-mediated drug-drug interaction between atomoxetine and bupropion in healthy volunteers. J Pharm Pharm Sci 2016,19(2),198-207","journal-title":"J Pharm Pharm Sci"},{"key":"ref=201","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/952584","volume":"\u2022\u2022\u2022","author":"Kasi P.M.","year":"2011","unstructured":"Kasi P.M.; Mounzer R.; Gleeson G.H.; Cardiovascular side effects of atomoxetine and its interactions with inhibitors of the cytochrome p450 system. Case Rep Med 2011,\u2022\u2022\u2022","journal-title":"Case Rep Med"},{"key":"ref=202","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1177\/009127002762491307","volume":"42","author":"Belle D.J.","year":"2002","unstructured":"Belle D.J.; Ernest C.S.; Sauer J.M.; Smith B.P.; Thomasson H.R.; Witcher J.W.; Effect of potent CYP2D6 inhibition by paroxetine on atomoxetine pharmacokinetics. J Clin Pharmacol 2002,42(11),1219-1227","journal-title":"J Clin Pharmacol"},{"key":"ref=203","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s40263-016-0349-0","volume":"30","author":"Reed V.A.","year":"2016","unstructured":"Reed V.A.; Buitelaar J.K.; Anand E.; Day K.A.; Treuer T.; Upadhyaya H.P.; Coghill D.R.; Kryzhanovskaya L.A.; Savill N.C.; The safety of atomoxetine for the treatment of children and adolescents with attention-deficit\/hyperactivity disorder: A comprehensive review of over a decade of research. CNS Drugs 2016,30(7),603-628","journal-title":"CNS Drugs"},{"key":"ref=204","doi-asserted-by":"publisher","DOI":"10.7573\/dic.212286","volume":"4","author":"Belkin M.R.","year":"2015","unstructured":"Belkin M.R.; Schwartz T.L.; Alpha-2 receptor agonists for the treatment of posttraumatic stress disorder. Drugs Context 2015,4","journal-title":"Drugs Context"},{"key":"ref=205","doi-asserted-by":"publisher","first-page":"499","DOI":"10.2147\/NDT.S1711","volume":"4","author":"Strange B.C.","year":"2008","unstructured":"Strange B.C.; Once-daily treatment of ADHD with guanfacine: patient implications. Neuropsychiatr Dis Treat 2008,4(3),499-506","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref=206","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/00004714-200104000-00015","volume":"21","author":"Taylor F.B.","year":"2001","unstructured":"Taylor F.B.; Russo J.; Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit\/hyperactivity disorder. J Clin Psychopharmacol 2001,21(2),223-228","journal-title":"J Clin Psychopharmacol"},{"key":"ref=207","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.psychres.2015.12.017","volume":"236","author":"Butterfield M.E.","year":"2016","unstructured":"Butterfield M.E.; Saal J.; Young B.; Young J.L.; Supplementary guanfacine hydrochloride as a treatment of attention deficit hyperactivity disorder in adults: A double blind, placebo-controlled study. Psychiatry Res 2016,236,136-141","journal-title":"Psychiatry Res"},{"key":"ref=208","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/JCP.0000000000000281","volume":"35","author":"Kim R.K.","year":"2015","unstructured":"Kim R.K.; Chayer R.; Psychosis associated with guanfacine. J Clin Psychopharmacol 2015,35(2),213","journal-title":"J Clin Psychopharmacol"},{"key":"ref=209","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1097\/00004583-200312000-00004","volume":"42","author":"Boreman C.D.","year":"2003","unstructured":"Boreman C.D.; Arnold L.E.; Hallucinations associated with initiation of guanfacine. J Am Acad Child Adolesc Psychiatry 2003,42(12),1387","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"ref=210","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0165-0327(98)00183-9","volume":"54","author":"Horrigan J.P.","year":"1999","unstructured":"Horrigan J.P.; Barnhill L.J.; Guanfacine and secondary mania in children. J Affect Disord 1999,54(3),309-314","journal-title":"J Affect Disord"},{"key":"ref=211","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1089\/cap.2016.0050","volume":"26","author":"Elbe D.","year":"2016","unstructured":"Elbe D.; Perel-Panar C.; Wicholas L.; Manic reaction in a child induced by guanfacine-extended release. J Child Adolesc Psychopharmacol 2016,26(6),566-567","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"ref=212","doi-asserted-by":"publisher","first-page":"171","DOI":"10.4137\/SART.S13019","volume":"7","author":"Fitzgerald P.J.","year":"2013","unstructured":"Fitzgerald P.J.; Elevated norepinephrine may be a unifying etiological factor in the abuse of a broad range of substances: Alcohol, nicotine, marijuana, heroin, cocaine, and caffeine. Subst Abuse 2013,7,171-183","journal-title":"Subst Abuse"},{"key":"ref=213","author":"Gourlay S.G.","year":"2004","unstructured":"Gourlay S.G.; Stead L.F.; Benowitz N.L.; Clonidine for smoking cessation. Cochrane Database Syst Rev 2004(3)","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=214","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/JCP.0b013e31819a4bae","volume":"29","author":"Ziegenhorn A.A.","year":"2009","unstructured":"Ziegenhorn A.A.; Roepke S.; Schommer N.C.; Merkl A.; Danker-Hopfe H.; Perschel F.H.; Heuser I.; Anghelescu I.G.; Lammers C.H.; Clonidine improves hyperarousal in borderline personality disorder with or without comorbid posttraumatic stress disorder: A randomized, double-blind, placebo-controlled trial. J Clin Psychopharmacol 2009,29(2),170-173","journal-title":"J Clin Psychopharmacol"},{"key":"ref=215","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1177\/1756283X15625586","volume":"9","author":"Fragkos K.C.","year":"2016","unstructured":"Fragkos K.C.; Z\u00e1rate-Lopez N.; Frangos C.C.; What about clonidine for diarrhoea? A systematic review and meta-analysis of its effect in humans. Therap Adv Gastroenterol 2016,9(3),282-301","journal-title":"Therap Adv Gastroenterol"},{"key":"ref=216","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1007\/s00228-016-2090-5","volume":"72","author":"Li L.","year":"2016","unstructured":"Li L.; Xu L.; Wu J.; Dong L.; Zhao S.; Zheng Q.; Comparative efficacy of nonhormonal drugs on menopausal hot flashes. Eur J Clin Pharmacol 2016,72(9),1051-1058","journal-title":"Eur J Clin Pharmacol"},{"key":"ref=217","doi-asserted-by":"publisher","first-page":"474","DOI":"10.2165\/00023210-199606060-00007","volume":"6","author":"Patel S.S.","year":"1996","unstructured":"Patel S.S.; Dunn C.J.; Bryson H.M.; Epidural Clonidine. CNS Drugs 1996,6(6),474-497","journal-title":"CNS Drugs"},{"key":"ref=218","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1177\/0960327112454896","volume":"32","author":"Kukoyi A.","year":"2013","unstructured":"Kukoyi A.; Coker S.; Lewis L.; Nierenberg D.; Two cases of acute dexmedetomidine withdrawal syndrome following prolonged infusion in the intensive care unit: Report of cases and review of the literature. Hum Exp Toxicol 2013,32(1),107-110","journal-title":"Hum Exp Toxicol"},{"key":"ref=219","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s40272-017-0262-0","volume":"20","author":"Rulong G.","year":"2018","unstructured":"Rulong G.; Dye T.; Simakajornboon N.; Pharmacological management of restless legs syndrome and periodic limb movement disorder in children. Paediatr Drugs 2018,20(1),9-17","journal-title":"Paediatr Drugs"},{"key":"ref=220","doi-asserted-by":"publisher","first-page":"329","DOI":"10.2165\/11208100-000000000-00000","volume":"13","author":"Croxtall J.D.","year":"2011","unstructured":"Croxtall J.D.; Clonidine extended-release: in attention-deficit hyperactivity disorder. Paediatr Drugs 2011,13(5),329-336","journal-title":"Paediatr Drugs"},{"key":"ref=221","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1080\/13543776.2016.1182989","volume":"26","author":"Molina-Carballo A.","year":"2016","unstructured":"Molina-Carballo A.; Checa-Ros A.; Mu\u00f1oz-Hoyos A.; Treatments and compositions for attention deficit hyperactivity disorder: a patent review. Expert Opin Ther Pat 2016,26(7),799-814","journal-title":"Expert Opin Ther Pat"},{"key":"ref=222","year":"2018)","unstructured":"Attention Deficit Hyperactivity Disorder in Children and Adolescents. In: Comparative Effectiveness Review Summary Guides for Clinicians, Rockville (MD), 2007. Available at: (Accessed Date: January 31st, 2018)"},{"key":"ref=223","unstructured":"[Accessed:December 8th, 2017]"},{"key":"ref=224","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1021\/ed077p1479","volume":"77","author":"Perrine D.M.","year":"2000","unstructured":"Perrine D.M.; Ross J.T.; Nervi S.J.; Zimmerman R.H.A.; Short, one-pot synthesis of bupropion (Zyban, Wellbutrin). J Chem Educ 2000,77(11),1479","journal-title":"J Chem Educ"},{"key":"ref=225","doi-asserted-by":"publisher","first-page":"106","DOI":"10.4088\/PCC.v07n0305","volume":"7","author":"Fava M.","year":"2005","unstructured":"Fava M.; Rush A.J.; Thase M.E.; Clayton A.; Stahl S.M.; Pradko J.F.; Johnston J.A.; 15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL. Prim Care Companion J Clin Psychiatry 2005,7(3),106-113","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"ref=226","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2165\/1159616-S0-000000000-00000","volume":"31","author":"Moreira R.","year":"2011","unstructured":"Moreira R.; The efficacy and tolerability of bupropion in the treatment of major depressive disorder. Clin Drug Investig 2011,31(Suppl. 1),5-17","journal-title":"Clin Drug Investig"},{"key":"ref=227","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2147\/DHPS.S7634","volume":"2","author":"Higgins A.","year":"2010","unstructured":"Higgins A.; Nash M.; Lynch A.M.; Antidepressant-associated sexual dysfunction: impact, effects, and treatment. Drug Healthc Patient Saf 2010,2,141-150","journal-title":"Drug Healthc Patient Saf"},{"key":"ref=228","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4088\/JCP.0906e09","volume":"67","author":"Baldwin D.S.","year":"2006","unstructured":"Baldwin D.S.; Papakostas G.I.; Symptoms of fatigue and sleepiness in major depressive disorder. J Clin Psychiatry 2006,67(Suppl. 6),9-15","journal-title":"J Clin Psychiatry"},{"key":"ref=229","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.neuropharm.2016.09.021","volume":"113","author":"Pandhare A.","year":"2017","unstructured":"Pandhare A.; Pappu A. S.; Wilms H.; Blanton M. P.; Jansen M.; The antidepressant bupropion is a negative allosteric modulator of serotonin type 3A receptors. Neuropharmacology 2017,113(Pt A),89-99"},{"key":"ref=230","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0006-3223(02)01664-5","volume":"54","author":"Wilens T.E.","year":"2003","unstructured":"Wilens T.E.; Prince J.B.; Spencer T.; Van Patten S.L.; Doyle R.; Girard K.; Hammerness P.; Goldman S.; Brown S.; Biederman J.; An open trial of bupropion for the treatment of adults with attention-deficit\/hyperactivity disorder and bipolar disorder. Biol Psychiatry 2003,54(1),9-16","journal-title":"Biol Psychiatry"},{"key":"ref=231","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/B978-0-12-394623-2.00014-7","volume":"89","author":"Ishizuka T.","year":"2012","unstructured":"Ishizuka T.; Murotani T.; Yamatodani A.; Action of modafinil through histaminergic and orexinergic neurons. Vitam Horm 2012,89,259-278","journal-title":"Vitam Horm"},{"key":"ref=232","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.4088\/JCP.13r08560","volume":"74","author":"Goss A.J.","year":"2013","unstructured":"Goss A.J.; Kaser M.; Costafreda S.G.; Sahakian B.J.; Fu C.H.; Modafinil augmentation therapy in unipolar and bipolar depression: a systematic review and meta-analysis of randomized controlled trials. J Clin Psychiatry 2013,74(11),1101-1107","journal-title":"J Clin Psychiatry"},{"key":"ref=233","doi-asserted-by":"publisher","first-page":"378","DOI":"10.4088\/JCP.v61n0510","volume":"61","author":"Menza M.A.","year":"2000","unstructured":"Menza M.A.; Kaufman K.R.; Castellanos A.; Modafinil augmentation of antidepressant treatment in depression. J Clin Psychiatry 2000,61(5),378-381","journal-title":"J Clin Psychiatry"},{"key":"ref=234","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jad.2015.04.012","volume":"181","author":"Ketter T.A.","year":"2015","unstructured":"Ketter T.A.; Yang R.; Frye M.A.; Adjunctive armodafinil for major depressive episodes associated with bipolar I disorder. J Affect Disord 2015,181,87-91","journal-title":"J Affect Disord"},{"key":"ref=235","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1212\/01.WNL.0000037481.08283.51","volume":"59","author":"MacDonald J.R.","year":"2002","unstructured":"MacDonald J.R.; Hill J.D.; Tarnopolsky M.A.; Modafinil reduces excessive somnolence and enhances mood in patients with myotonic dystrophy. Neurology 2002,59(12),1876-1880","journal-title":"Neurology"},{"key":"ref=236","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1177\/088307380201700303","volume":"17","author":"Hurst D.L.","year":"2002","unstructured":"Hurst D.L.; Lajara-Nanson W.; Use of modafinil in spastic cerebral palsy. J Child Neurol 2002,17(3),169-172","journal-title":"J Child Neurol"},{"key":"ref=237","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/00002826-200203000-00010","volume":"25","author":"Nieves A.V.","year":"2002","unstructured":"Nieves A.V.; Lang A.E.; Treatment of excessive daytime sleepiness in patients with Parkinson\u2019s disease with modafinil. Clin Neuropharmacol 2002,25(2),111-114","journal-title":"Clin Neuropharmacol"},{"key":"ref=238","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nrgastro.2010.62","volume":"7","author":"Abbas G.","year":"2010","unstructured":"Abbas G.; Jorgensen R.A.; Lindor K.D.; Fatigue in primary biliary cirrhosis. Nat Rev Gastroenterol Hepatol 2010,7(6),313-319","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref=239","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.biopsych.2012.03.022","volume":"72","author":"Loland C.J.","year":"2012","unstructured":"Loland C.J.; Mereu M.; Okunola O.M.; Cao J.; Prisinzano T.E.; Mazier S.; Kopajtic T.; Shi L.; Katz J.L.; Tanda G.; Newman A.H.; R-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse. Biol Psychiatry 2012,72(5),405-413","journal-title":"Biol Psychiatry"},{"key":"ref=240","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1023\/B:NERE.0000029559.20581.1a","volume":"29","author":"Chatterjie N.","year":"2004","unstructured":"Chatterjie N.; Stables J.P.; Wang H.; Alexander G.J.; Anti-narcoleptic agent modafinil and its sulfone: a novel facile synthesis and potential anti-epileptic activity. Neurochem Res 2004,29(8),1481-1486","journal-title":"Neurochem Res"},{"key":"ref=241","first-page":"664","volume":"28","author":"Robertson P.","year":"2000","unstructured":"Robertson P.; DeCory H.H.; Madan A.; Parkinson A.; In vitro inhibition and induction of human hepatic cytochrome P450 enzymes by modafinil. Drug Metab Dispos 2000,28(6),664-671","journal-title":"Drug Metab Dispos"},{"key":"ref=242","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2014.12.005","volume":"147","author":"Reith M.E.","year":"2015","unstructured":"Reith M.E.; Blough B.E.; Hong W.C.; Jones K.T.; Schmitt K.C.; Baumann M.H.; Partilla J.S.; Rothman R.B.; Katz J.L.; Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter. Drug Alcohol Depend 2015,147,1-19","journal-title":"Drug Alcohol Depend"},{"key":"ref=243","first-page":"389","volume":"4","author":"Kolar D.","year":"2008","unstructured":"Kolar D.; Keller A.; Golfinopoulos M.; Cumyn L.; Syer C.; Hechtman L.; Treatment of adults with attention-deficit\/hyperactivity disorder. Neuropsychiatr Dis Treat 2008,4(2),389-403","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref=244","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.psc.2003.12.001","volume":"27","author":"Spencer T.","year":"2004","unstructured":"Spencer T.; Biederman J.; Wilens T.; Nonstimulant treatment of adult attention-deficit\/hyperactivity disorder. Psychiatr Clin North Am 2004,27(2),373-383","journal-title":"Psychiatr Clin North Am"},{"key":"ref=245","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1097\/01.chi.0000189135.05060.8a","volume":"45","author":"Findling R.L.","year":"2006","unstructured":"Findling R.L.; McNamara N.K.; Stansbrey R.; Gracious B.L.; Whipkey R.E.; Demeter C.A.; Reed M.D.; Youngstrom E.A.; Calabrese J.R.; Combination lithium and divalproex sodium in pediatric bipolar symptom re-stabilization. J Am Acad Child Adolesc Psychiatry 2006,45(2),142-148","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"ref=246","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1586\/14737175.2016.1135735","volume":"16","author":"Buoli M.","year":"2016","unstructured":"Buoli M.; Serati M.; Cahn W.; Alternative pharmacological strategies for adult ADHD treatment: a systematic review. Expert Rev Neurother 2016,16(2),131-144","journal-title":"Expert Rev Neurother"},{"key":"ref=247","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1517\/13543784.16.9.1365","volume":"16","author":"Chen Z.","year":"2007","unstructured":"Chen Z.; Skolnick P.; Triple uptake inhibitors: therapeutic potential in depression and beyond. Expert Opin Investig Drugs 2007,16(9),1365-1377","journal-title":"Expert Opin Investig Drugs"},{"key":"ref=248","author":"A. Randomized","unstructured":"A. Randomized; Double Blind, Multicenter, Placebo Controlled, Parallel Group, Efficacy and Safety Study of 2 Doses of Dasotraline in Adults With Attention Deficit Hyperactivity Disorder (ADHD). Available at: [Accessed: December 8th, 2017]"},{"key":"ref=249","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1038\/npp.2015.124","volume":"40","author":"Koblan K.S.","year":"2015","unstructured":"Koblan K.S.; Hopkins S.C.; Sarma K.; Jin F.; Goldman R.; Kollins S.H.; Loebel A.; Dasotraline for the treatment of attention-deficit\/hyperactivity disorder: A randomized, double-blind, placebo-controlled, proof-of-concept trial in adults. Neuropsychopharmacology 2015,40(12),2745-2752","journal-title":"Neuropsychopharmacology"},{"key":"ref=250","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1212\/WNL.0000000000000615","volume":"83","author":"Kaufmann H.","year":"2014","unstructured":"Kaufmann H.; Freeman R.; Biaggioni I.; Low P.; Pedder S.; Hewitt L.A.; Mauney J.; Feirtag M.; Mathias C.J.; Investigators N.O.H.; Droxidopa for neurogenic orthostatic hypotension: A randomized, placebo-controlled, phase 3 trial. Neurology 2014,83(4),328-335","journal-title":"Neurology"},{"key":"ref=251","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1177\/1087054715580393","volume":"23","author":"Adler L.A.","year":"2015","unstructured":"Adler L.A.; Gorny S.W.; Pilot study of droxidopa with carbidopa in adults with ADHD. J Atten Disord 2015,23(2),189-198","journal-title":"J Atten Disord"},{"key":"ref=252","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/S0893-133X(01)00298-6","volume":"25","author":"Bymaster F.P.","year":"2001","unstructured":"Bymaster F.P.; Dreshfield-Ahmad L.J.; Threlkeld P.G.; Shaw J.L.; Thompson L.; Nelson D.L.; Hemrick-Luecke S.K.; Wong D.T.; Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors. Neuropsychopharmacology 2001,25(6),871-880","journal-title":"Neuropsychopharmacology"},{"key":"ref=253","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/hup.1158","volume":"25","author":"Riahi F.","year":"2010","unstructured":"Riahi F.; Tehrani-Doost M.; Shahrivar Z.; Alaghband-Rad J.; Efficacy of reboxetine in adults with attention-deficit\/hyperactivity disorder: a randomized, placebo-controlled clinical trial. Hum Psychopharmacol 2010,25(7-8),570-576","journal-title":"Hum Psychopharmacol"},{"key":"ref=254","first-page":"231","volume":"19","author":"Hashemian F.","year":"2011","unstructured":"Hashemian F.; Mohammadian S.; Riahi F.; Ghaeli P.; Ghodsi D.; A comparison of the effects of reboxetine and placebo on reaction time in adults with Attention Deficit-Hyperactivity Disorder (ADHD). Daru 2011,19(3),231-235","journal-title":"Daru"},{"key":"ref=255","first-page":"779","volume":"31","author":"Hedges D.","year":"1995","unstructured":"Hedges D.; Reimherr F.W.; Rogers A.; Strong R.; Wender P.H.; An open trial of venlafaxine in adult patients with attention deficit hyperactivity disorder. Psychopharmacol Bull 1995,31(4),779-783","journal-title":"Psychopharmacol Bull"},{"key":"ref=256","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/hup.1274","volume":"27","author":"Amiri S.","year":"2012","unstructured":"Amiri S.; Farhang S.; Ghoreishizadeh M.A.; Malek A.; Mohammadzadeh S.; Double-blind controlled trial of venlafaxine for treatment of adults with attention deficit\/hyperactivity disorder. Hum Psychopharmacol 2012,27(1),76-81","journal-title":"Hum Psychopharmacol"},{"key":"ref=257","first-page":"785","volume":"31","author":"Adler L.A.","year":"1995","unstructured":"Adler L.A.; Resnick S.; Kunz M.; Devinsky O.; Open-label trial of venlafaxine in adults with attention deficit disorder. Psychopharmacol Bull 1995,31(4),785-788","journal-title":"Psychopharmacol Bull"},{"key":"ref=258","first-page":"184","volume":"57","author":"Findling R.L.","year":"1996","unstructured":"Findling R.L.; Schwartz M.A.; Flannery D.J.; Manos M.J.; Venlafaxine in adults with attention-deficit\/hyperactivity disorder: An open clinical trial. J Clin Psychiatry 1996,57(5),184-189","journal-title":"J Clin Psychiatry"},{"key":"ref=259","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3810\/pgm.2014.09.2795","volume":"126","author":"Manor I.","year":"2014","unstructured":"Manor I.; Rubin J.; Daniely Y.; Adler L.A.; Attention benefits after a single dose of metadoxine extended release in adults with predominantly inattentive ADHD. Postgrad Med 2014,126(5),7-16","journal-title":"Postgrad Med"},{"key":"ref=260","unstructured":"260] The MEASURE Study - A Phase 3 Study of MDX 1400 mg Daily Compared With Placebo in Adults With ADHD.Available at: [Accessed: December 8th, 2017]"},{"key":"ref=261","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1177\/1087054707299367","volume":"11","author":"Sandra Kooij J.J.","year":"2008","unstructured":"Sandra Kooij J.J.; Marije Boonstra A.; Swinkels S.H.; Bekker E.M.; de Noord I.; Buitelaar J.K.; Reliability, validity, and utility of instruments for self-report and informant report concerning symptoms of ADHD in adult patients. J Atten Disord 2008,11(4),445-458","journal-title":"J Atten Disord"},{"key":"ref=262","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1176\/ajp.150.12.1792","volume":"150","author":"Biederman J.","year":"1993","unstructured":"Biederman J.; Faraone S.V.; Spencer T.; Wilens T.; Norman D.; Lapey K.A.; Mick E.; Lehman B.K.; Doyle A.; Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry 1993,150(12),1792-1798","journal-title":"Am J Psychiatry"},{"key":"ref=263","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.4088\/JCP.08m04785pur","volume":"70","author":"Wilens T.E.","year":"2009","unstructured":"Wilens T.E.; Biederman J.; Faraone S.V.; Martelon M.; Westerberg D.; Spencer T.J.; Presenting ADHD symptoms, subtypes, and comorbid disorders in clinically referred adults with ADHD. J Clin Psychiatry 2009,70(11),1557-1562","journal-title":"J Clin Psychiatry"},{"key":"ref=264","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1007\/s11920-007-0055-1","volume":"9","author":"Gibbins C.","year":"2007","unstructured":"Gibbins C.; Weiss M.; Clinical recommendations in current practice guidelines for diagnosis and treatment of ADHD in adults. Curr Psychiatry Rep 2007,9(5),420-426","journal-title":"Curr Psychiatry Rep"},{"key":"ref=265","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1176\/appi.ajp.159.11.1882","volume":"159","author":"Mannuzza S.","year":"2002","unstructured":"Mannuzza S.; Klein R.G.; Klein D.F.; Bessler A.; Shrout P.; Accuracy of adult recall of childhood attention deficit hyperactivity disorder. Am J Psychiatry 2002,159(11),1882-1888","journal-title":"Am J Psychiatry"},{"key":"ref=266","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1177\/1087054706289941","volume":"10","author":"Belendiuk K.A.","year":"2007","unstructured":"Belendiuk K.A.; Clarke T.L.; Chronis A.M.; Raggi V.L.; Assessing the concordance of measures used to diagnose adult ADHD. J Atten Disord 2007,10(3),276-287","journal-title":"J Atten Disord"},{"key":"ref=267","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.neulet.2004.12.051","volume":"379","author":"Najt P.","year":"2005","unstructured":"Najt P.; Glahn D.; Bearden C.E.; Hatch J.P.; Monkul E.S.; Kaur S.; Villarreal V.; Bowden C.; Soares J.C.; Attention deficits in bipolar disorder: a comparison based on the continuous performance test. Neurosci Lett 2005,379(2),122-126","journal-title":"Neurosci Lett"},{"key":"ref=268","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.pnpbp.2006.04.016","volume":"30","author":"Bora E.","year":"2006","unstructured":"Bora E.; Vahip S.; Akdeniz F.; Sustained attention deficits in manic and euthymic patients with bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 2006,30(6),1097-1102","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=269","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/j.1399-5618.2009.00678.x","volume":"11","author":"Swann A.C.","year":"2009","unstructured":"Swann A.C.; Lijffijt M.; Lane S.D.; Steinberg J.L.; Moeller F.G.; Increased trait-like impulsivity and course of illness in bipolar disorder. Bipolar Disord 2009,11(3),280-288","journal-title":"Bipolar Disord"},{"key":"ref=270","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1399-5618.2010.00806.x","volume":"12","author":"Strakowski S.M.","year":"2010","unstructured":"Strakowski S.M.; Fleck D.E.; DelBello M.P.; Adler C.M.; Shear P.K.; Kotwal R.; Arndt S.; Impulsivity across the course of bipolar disorder. Bipolar Disord 2010,12(3),285-297","journal-title":"Bipolar Disord"},{"key":"ref=271","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jad.2014.06.053","volume":"168","author":"Perroud N.","year":"2014","unstructured":"Perroud N.; Cordera P.; Zimmermann J.; Michalopoulos G.; Bancila V.; Prada P.; Dayer A.; Aubry J.M.; Comorbidity between attention deficit hyperactivity disorder (ADHD) and bipolar disorder in a specialized mood disorders outpatient clinic. J Affect Disord 2014,168,161-166","journal-title":"J Affect Disord"},{"key":"ref=272","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jad.2005.09.006","volume":"89","author":"Paelecke-Habermann Y.","year":"2005","unstructured":"Paelecke-Habermann Y.; Pohl J.; Leplow B.; Attention and executive functions in remitted major depression patients. J Affect Disord 2005,89(1-3),125-135","journal-title":"J Affect Disord"},{"key":"ref=273","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/j.1399-5618.2007.00324.x","volume":"9","author":"Malhi G.S.","year":"2007","unstructured":"Malhi G.S.; Ivanovski B.; Hadzi-Pavlovic D.; Mitchell P.B.; Vieta E.; Sachdev P.; Neuropsychological deficits and functional impairment in bipolar depression, hypomania and euthymia. Bipolar Disord 2007,9(1-2),114-125","journal-title":"Bipolar Disord"},{"key":"ref=274","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/j.1399-5618.2006.00293.x","volume":"8","author":"Jaideep T.","year":"2006","unstructured":"Jaideep T.; Reddy Y.C.; Srinath S.; Comorbidity of attention deficit hyperactivity disorder in juvenile bipolar disorder. Bipolar Disord 2006,8(2),182-187","journal-title":"Bipolar Disord"},{"key":"ref=275","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1176\/appi.ajp.157.3.466","volume":"157","author":"Sachs G.S.","year":"2000","unstructured":"Sachs G.S.; Baldassano C.F.; Truman C.J.; Guille C.; Comorbidity of attention deficit hyperactivity disorder with early- and late-onset bipolar disorder. Am J Psychiatry 2000,157(3),466-468","journal-title":"Am J Psychiatry"},{"key":"ref=276","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/j.1399-5618.2006.00342.x","volume":"8","author":"Masi G.","year":"2006","unstructured":"Masi G.; Perugi G.; Toni C.; Millepiedi S.; Mucci M.; Bertini N.; Pfanner C.; Attention-deficit hyperactivity disorder -- bipolar comorbidity in children and adolescents. Bipolar Disord 2006,8(4),373-381","journal-title":"Bipolar Disord"},{"key":"ref=277","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.psychres.2007.06.016","volume":"161","author":"Sentissi O.","year":"2008","unstructured":"Sentissi O.; Navarro J.C.; De Oliveira H.; Gourion D.; Bourdel M.C.; Bayl\u00e9 F.J.; Oli\u00e9 J.P.; Poirier M.F.; Bipolar disorders and quality of life: the impact of attention deficit\/hyperactivity disorder and substance abuse in euthymic patients. Psychiatry Res 2008,161(1),36-42","journal-title":"Psychiatry Res"},{"key":"ref=278","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jad.2010.12.007","volume":"131","author":"Brand S.","year":"2011","unstructured":"Brand S.; Gerber M.; P\u00fchse U.; Holsboer-Trachsler E.; \u2018Bright side\u2019 and \u2018dark side\u2019 hypomania are associated with differences in psychological functioning, sleep and physical activity in a non-clinical sample of young adults. J Affect Disord 2011,131(1-3),68-78","journal-title":"J Affect Disord"},{"key":"ref=279","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.3389\/fpsyg.2017.02130","volume":"8","author":"Jahangard L.","year":"2017","unstructured":"Jahangard L.; Rahmani A.; Haghighi M.; Ahmadpanah M.; Sadeghi Bahmani D.; Soltanian A.R.; Shirzadi S.; Bajoghli H.; Gerber M.; Holsboer-Trachsler E.; Brand S.; \u201cAlways Look on the Bright Side of Life!\u201d - higher hypomania scores are associated with higher mental toughness, increased physical activity, and lower symptoms of depression and lower sleep complaints. Front Psychol 2017,8,2130","journal-title":"Front Psychol"},{"key":"ref=280","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.tics.2017.03.009","volume":"21","author":"Mueller A.","year":"2017","unstructured":"Mueller A.; Hong D.S.; Shepard S.; Moore T.; Linking ADHD to the neural circuitry of attention. Trends CognSci (Regul Ed), 2017,21(6),474-488","journal-title":"Trends CognSci (Regul Ed),"},{"key":"ref=281","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.3389\/fpsyg.2016.01682","volume":"7","author":"Mucci N.","year":"2016","unstructured":"Mucci N.; Giorgi G.; De Pasquale Ceratti S.; Fiz-P\u00e9rez J.; Mucci F.; Arcangeli G.; Anxiety, stress-related factors, and blood pressure in young adults. Front Psychol 2016,7,1682","journal-title":"Front Psychol"},{"key":"ref=282","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jad.2016.03.047","volume":"198","author":"Richard-Lepouriel H.","year":"2016","unstructured":"Richard-Lepouriel H.; Etain B.; Hasler R.; Bellivier F.; Gard S.; Kahn J.P.; Prada P.; Nicastro R.; Ardu S.; Dayer A.; Leboyer M.; Aubry J.M.; Perroud N.; Henry C.; Similarities between emotional dysregulation in adults suffering from ADHD and bipolar patients. J Affect Disord 2016,198,230-236","journal-title":"J Affect Disord"},{"key":"ref=283","doi-asserted-by":"publisher","first-page":"PCC.12m01495.","DOI":"10.4088\/PCC.12m01495","volume":"15","author":"Marin A.","year":"2013","unstructured":"Marin A.; Scott D.; Groll D.L.; Bipolar disorder comorbid with attention-deficit\/hyperactivity disorder in adult inpatients with acute relapse. Prim Care Companion CNS Disord, 2013,15(4),PCC.12m01495.","journal-title":"Prim Care Companion CNS Disord,"},{"key":"ref=284","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00406-008-0807-x","volume":"258","author":"Tamam L.","year":"2008","unstructured":"Tamam L.; Karakus G.; Ozpoyraz N.; Comorbidity of adult attention-deficit hyperactivity disorder and bipolar disorder: prevalence and clinical correlates. Eur Arch Psychiatry Clin Neurosci 2008,258(7),385-393","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"ref=285","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/j.1469-7610.2008.02040.x","volume":"50","author":"Biederman J.","year":"2009","unstructured":"Biederman J.; Petty C.R.; Monuteaux M.C.; Mick E.; Clarke A.; Ten Haagen K.; Faraone S.V.; Familial risk analysis of the association between attention-deficit\/hyperactivity disorder and psychoactive substance use disorder in female adolescents: a controlled study. J Child Psychol Psychiatry 2009,50(3),352-358","journal-title":"J Child Psychol Psychiatry"},{"key":"ref=286","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1176\/appi.ajp.2007.07101614","volume":"165","author":"Adler L.A.","year":"2008","unstructured":"Adler L.A.; Familial transmission of ADHD and psychoactive substance use disorders. Am J Psychiatry 2008,165(1),11-12","journal-title":"Am J Psychiatry"},{"key":"ref=287","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s11920-013-0375-2","volume":"15","author":"Rabiner D.L.","year":"2013","unstructured":"Rabiner D.L.; Stimulant prescription cautions: addressing misuse, diversion and malingering. Curr Psychiatry Rep 2013,15(7),375","journal-title":"Curr Psychiatry Rep"},{"key":"ref=288","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1093\/arclin\/acx113","volume":"33","author":"Aita S.L.","year":"2018","unstructured":"Aita S.L.; Sofko C.A.; Hill B.D.; Musso M.W.; Boettcher A.C.; Utility of the personality assessment inventory in detecting feigned Attention-Deficit\/Hyperactivity Disorder (ADHD): The feigned adult ADHD index. Arch Clin Neuropsychol 2018,33(7),832-844","journal-title":"Arch Clin Neuropsychol"},{"key":"ref=289","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/7854_2015_426","volume":"34","author":"Clemow D.B.","year":"2017","unstructured":"Clemow D.B.; Misuse of methylphenidate. Curr Top Behav Neurosci 2017,34,99-124","journal-title":"Curr Top Behav Neurosci"},{"key":"ref=290","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/j.1521-0391.2010.00078.x","volume":"19","author":"Upadhyaya H.P.","year":"2010","unstructured":"Upadhyaya H.P.; Kroutil L.A.; Deas D.; Durell T.M.; Van Brunt D.L.; Novak S.P.; Stimulant formulation and motivation for nonmedical use of prescription attention-deficit\/hyperactivity disorder medications in a college-aged population. Am J Addict 2010,19(6),569-577","journal-title":"Am J Addict"},{"key":"ref=291","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1080\/13548500802126723","volume":"14","author":"Judson R.","year":"2009","unstructured":"Judson R.; Langdon S.W.; Illicit use of prescription stimulants among college students: prescription status, motives, theory of planned behaviour, knowledge and self-diagnostic tendencies. Psychol Health Med 2009,14(1),97-104","journal-title":"Psychol Health Med"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/174105","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,25]],"date-time":"2022-09-25T06:57:57Z","timestamp":1664089077000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/174105\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,3]]},"references-count":291,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2019,1,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867326666190805153610","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-01-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-06-05","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}